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Preface 
As a medical student, you earn so much information and 
knowledge about diabetic patients and their complications, but only when 
you see a neglected diabetic foot ulcer with gangrene in A&E department 
during your surgical rotation, you realize the difficulty in management of 
the diabetic foot for both the patient and the physician. Thereafter, you 
watch the residents from every specialty (General Surgery, Orthopedics, 
Vascular Surgeons, Dermatologists, Endocrinologists or Internal 
Medicine etc), how hard they try to refer this diabetic patient to each 
other. Nobody wants to be involved with the management of such a 
difficult patient. On the other hand, a multidisciplinary team approach 
including many specialties would be the ideal management for such a 
patient with foot ulcer in order to increase the likelihood of ulcer healing 
and limb salvage.  
Mr. Philip Chan (who was my supervisor in Sheffield, and a friend 
of mine now) and Prof. Giannoukas (who is my supervisor and teacher 
now) encouraged me to undertake this observational study in our region 
(Thessaly) including the diabetic patients with foot ulcer, and to assess  
their management and follow up for 12 months.  Dr. A. Bargiota (who is 
the head of the Endocrinology Department) contributed to the 
management of those diabetic patients and counseled us constantly. Thus, 
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we tried to apply the principles of a multidisciplinary team approach in a 
small scale in our University Hospital, with the contribution also of 
Orthopedics and General Surgeons when needed. 
At the beginning, we conducted a survey under the guidance of the 
Mediterranean League of Angiology and Vascular Surgery (MLAVS) in 
order to highlight the current trends in the management of diabetic foot 
among Vascular Specialists practicing in the Mediterranean region. 
During the clinical assessment, management and follow up of 
diabetic patients, we validated the Leeds Assessment of Neuropathic 
Symptoms and Signs (LANSS) questionnaire in Greek population, 
assessed factors associated with the healing process or limb salvage, and 
evaluated the impact of their treatment on their quality of life (QOL). 
Diabetic foot ulcer is a worldwide problem with a great impact on 
health care cost, the quality of life of the patient and its social 
environment and finally on the mortality and morbidity of those patients. 
Medical society should take more seriously this huge socio-economical 
clinical problem and not consider it an issue of one physician alone but a 
problem that need the attention and management of an organized 
multidisciplinary team. 
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Part A 
 
1. Introduction 
 
Diabetes mellitus (DM) is a group of metabolic diseases 
characterized by chronic hyperglycemia resulting from defects in insulin 
secretion, insulin action, or both. Metabolic abnormalities in 
carbohydrates, lipids, and proteins result from the importance of insulin 
as an anabolic hormone. Low levels of insulin to achieve adequate 
response and/or insulin resistance of target tissues, mainly skeletal 
muscles, adipose tissue, and to a lesser extent, liver, at the level of insulin 
receptors, signal transduction system, and/or effect or enzymes or genes 
are responsible for these metabolic abnormalities. The severity of 
symptoms is due to the type and duration of diabetes.
1 
One of the most 
insidious and life threatening complication and even in some cases 
clinical presentation is diabetic foot ulcer (DFU). 
According to the World Health Organization (WHO), it is possible 
to encompass all foot complications in the term diabetic foot syndrome 
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that has been defined as “ulceration of the foot associated with 
neuropathy and different grades of ischemia and infection.”2 
 The medical and surgical management of DFU should have as its 
basis a thorough understanding of the complications and metabolic 
consequences of DM and a multidisciplinary approach from co-operating 
specialties. 
 
2. History of wound healing
 
 
Human’s struggle against wound healing is as old as itself.3 The 
first report in history was described by Egyptians who repaired their 
wounds with primitive suture materials and used clean sheets on surgical 
field to prevent ‘suppuration’. In Greece, Hippocrates had developed 
treatment methods for primary and chronic wounds. He used various 
gauze materials empirically such as wine, milk, honey and other 
sunstances in open wounds which have lot similarities with our treatment 
options today. For example wine may suppress pseudomonas 
proliferation, complex sugar of honey are known to suppress the growth 
of Gram-positive bacteria and milk products may contains cytokines or 
serve as buffers to control wound pH. Although the ancients did not know 
the composition of pus, they had understood that the drainage of localized 
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products of infection was a good sign. In cases when signs of 
inflammation could not be localized, they had understood that death 
would follow. During the early Roman era, even though Celsius was not 
aware of the existence of bacteria, he recognized and described the 
cardinal signs of clinical infection being: erythema (rubor), swelling 
(tumor), pain (dolor) and heat (calor).
3,4 
 The ancients reached by their available means a scientific approach 
to wound healing by their observations, rationale and conclusions. 
However, the sequel was not the expected one. During the Dark Ages the 
domination of the church over the thought process overran the free 
thinkers in the arts and the sciences. Nevertheless, great minds interested 
in science, anatomy and evolution could not be suppressed. In the 17
th
 
century, John Hunter was the first one to describe angiogenesis. In the 
18
th
 and 19
th
 centuries came the recognition that a factor passed from care 
givers to patients, would kill them. These observations were made by 
Holmes, Sommelweiss and many others which promoted the discovery of 
bacteria by Pasteur and the concept of antisespis by Lister.
3,5 
 It was Claude Bernard (1813-1878) who really played a major role 
in development of laboratory methods for the of clinical medicine and 
thus advancements that would evolve wound healing treatment in general 
and diabetic wounds in particular. The late 19
th
 to mid-20
th
 century saw 
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the evolution of antibiotics which had more positive effects on wound 
healing than negative ones. Thus Fleming and his associates (Chain and 
Florey) discovered penicillin by studying the mold. Keen and simple 
observations had changed the course of medical history for the better.
3 
 However, in the 1940s was the first time in history that healing 
studies involved cell cultures, animal models and eventually human 
studies. Alexis Carrel was the father of modern day wound healing 
studies. He grew fibroblasts in cultures, studied wound contraction in 
World War I combat injuries and did the first microsurgery for which he 
was awarded the Nobel Prize. By the end of World War II, Egbert 
Dumphy, at Harvard, started a series of experiments in animals and 
humans examining a number of factors including nutrition, oxygen, shock 
and so on. Stan Levinson experienced on burn victims, shock and their 
metabolism. These two surgical leaders published the first texts and 
symposium on wound healing and inspired and trained future leaders in 
wound healing research.
3
  
 Since the 1970s there had been a logarithmic growth in the 
laboratory tools available to seek answers to the mystery of wound 
healing pathogenesis in general and diabetic wounds in particular, such as 
tissue cultures, electron microscopy, protein analysis, Western blot, 
Northern blot, PCR (polymerase chain reaction) and now gene array. 
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Perhaps, the last one; the defining structure and means for analysis of 
DNA and RNA was the greatest discovery of all. Rosalind Fraklin, 
Watson and Crick led the advancements to identify rapidly protein 
structure, map genes and characterize materials with great speed 
accuracy. The aggregation of biological information for wound healing 
process and its treatment was dramatically increased those last years. 
Those discoveries have created new prospects for our understanding and 
treatment of the diabetic wound problem. Many of these advances have 
been resulting from Federal Governments and via National Institutes of 
Health. However, unfortunately in recent and present history the most 
interesting phenomenon is the discovery that wound care is a market 
worth billions of money, which is something that could be extremely 
dangerous for the diabetic foot patients and their treatment in the near 
future. 
3
  
 
3. Epidemiology 
 
The classical classification of diabetes as proposed by the 
American Diabetes Association (ADA) in 1997 as type 1, type 2, other 
types, and gestational diabetes mellitus (GDM) is still the most accepted 
classification and adopted by ADA.
1 
During past decades, a distressing 
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increase in the prevalence of diabetes has been observed and especially in 
DM II. In the Framingham study, the prevalence had risen from 0.9% in 
1958 to 3% in 1995.
6
 Later on, the centers for disease control in 2001 
estimated the US prevalence of diagnosed DM at 7.3% which was quite 
higher in comparison with a similar study in 1990 reporting 4.9%, 
representing nearly a 48% increase over the decade.
7
 Recently, in the year 
2009, the estimated number of youth in the United States younger than 20 
years with type 1 diabetes was recorded 166984.
8
 The prevalence of type 
1 diabetes in the world is not known but in the United States in youth 
younger than 20 years was 1.93 per 1000 in 2009 (0.35-2.55 in different 
ethnic groups) with 2.6%-2.7% relative annual increase.
9
In addition, 
nowadays there are many  individuals with prediabetes who do not meet 
the criteria of having diabetes but are at high risk to develop type 2 
diabetes in the future. According to the ADA Expert Committee, 
prediabetes is defined as pathological condition in cases in which either 
impaired fasting plasma glucose (IFG) levels are between 100-125 mg/dL 
(5.6-6.9 mmol/L) or impaired glucose tolerance test (IGT) with 2-h 
plasma glucose levels in the oral glucose tolerance test (OGTT) is 
between 140-199 mg/dL (7.8-11.0 mmol/L). However the WHO still 
adopts the range for IFG from 110-125 mg/dL (6.1-6.9 mmol/L).
10 
In 
2013, it was reported by the International Diabetes Federation (IDF) that 
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the global prevalence of diabetes in adults is 8.3% (382 million people), 
with 14 million more men than women (198 million men vs 184 million 
women). 
11 
The higher prevalence was noticed between the ages 40 and 59 
years and the number is expected to rise beyond 592 million by 2035 with 
a 10.1% global prevalence.
11
 The Middle East and North Africa region 
has the highest prevalence of diabetes (10.9%), however, Western Pacific 
region has the highest number of adults diagnosed with diabetes (138.2 
millions) and has also countries with the highest prevalence.
9 
Most of the 
cases are being presented in low- and middle income countries in 80% of 
the cases, “where the epidemic is gathering pace at alarming rates”. 
(Figure 1) It is of note, that indigenous people of America and Polynesia 
are those with the highest risk; the Pima tribe in Arizona has the highest 
prevalence of DM II in the world, affecting nearly 50% of all adult 
members. 
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Figure 1. Comparative prevalence of diabetes in adults (20-79 years) in 
countries with high prevalence (>10%). 
 
 
 
 
 
In accordance to this rise of DM prevalence worldwide, is the 
increase of DFU incidence among diabetic patients. This is a reality that 
is taking place not only in developing countries, but in developed ones 
too although they have evolved their health systems. For example in 
Denmark, approximately 22,000 diabetic Danish patients are diagnosed 
with DFU, and each year approximately 3,000 new patients are added to 
this population. 
12
 In Canada, Out of 2.7 million patients living with DM 
in 2010, the probability of developing DFU in their lifetime was 15 
percent/year.
13
 In the US, DFU prevalence among persons aged 44 years 
was 6.5/1000 diabetics and it rose progressively to 10.3/1000 diabetics in 
individuals aged 75 years. In addition, the rate of hospital discharges with 
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DFU for 1000 diabetic patients rose from 5.4 in 1980 to 6.9 in 2003.
14 
These results are becoming worse in developing countries, such in Africa 
countries in which the frequency of diabetic patients with DFU may reach 
in some areas as high as 69%.
15  
 
It is apparent that DFU was always a multinational burden and this 
concept yielded results starting with the St. Vincent Declaration which 
was a set of goals for the health care of people with DM and 
was published as the product of an international conference held in St. 
Vincent, Italy, on 10-12 October 1989.
16 
Representatives of government 
health departments and patients' organizations from most European 
countries met with diabetes experts under the aegis of the WHO Europe 
and the IDF Europe. General standards for diabetes care were agreed on, 
as well as plans for improving care and in particular diabetic foot care in 
participating countries toward the goals. Consequently the St Vincent 
Declaration inspired other regional partnerships between the IDF and 
WHO, especially in response to the emerging pandemic of DM II: the 
Declaration of the Americas or DOTA (1996), the Western Pacific 
Declaration on Diabetes (WPDD 2000), and the Declaration and Diabetes 
Strategy for Sub-Saharan Africa (2006). 
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4. Health care cost 
 
The cost of care for diabetic patients with DFU is a major 
economic burden worldwide in comparison with the management of 
diabetic patients without ulceration. Cost will play an ever-increasing role 
because third-party payers cannot reimburse all therapies used to treat 
DFU in every country and for every patient. 
During past decades many studies have taken place, trying to 
estimate and unmask the magnitude of cost related to DFU worldwide.  
An analysis of Medicare claims data from 1995 to 1996 showed that 
expenditures for DFU patients were three times higher than for the 
general population ($15,309 vs  $5226), yielding a total cost for Medicare 
in 1995 of $1.5 billion.
17
 Lower extremity ulcers accounted for 24% of 
the overall cost for diabetic population with an ulcer. Most of the ulcer-
related costs accrued on the inpatient side (73.7%); proportionately 
smaller amounts went to physicians and nursing home facilities.
17 
Ramsey et al.
18 
demonstrated in a retrospective nested case-control study 
that the relative cost of care for diabetic patients with DFU ranges from 
1.5 to 2.4 times higher than that of diabetic patients without an ulcer in 
the year before diagnosis to 5.4 times higher in the year after the ulcer 
episode. The cost of care for diabetic patients with DFU showed a 
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tendency to return to the non-ulcer group only after 2 years from the first 
diagnosis, but was still 2.8 times higher. Excess cost was $26,490 in ulcer 
patients during the year of the ulcer episode and $4927 for diabetic 
patients without an ulcer. The excess cost persisted during the second 
year after the ulcer episode. Diabetic patients with DFU had more 
inpatient hospital days than diabetic patients without ulcers (6.03 vs 1.46 
days), and this difference was still significant 1 year after the ulcer 
episode (4.06 vs 2.61). In addition, diabetic foot patients had more 
emergency department visits during the first year of the study (0.42 vs 
0.18) and more non-emergency outpatient visits (35.08 vs 13.05).
18 
In a retrospective economic analysis based on a prospective study of 
consecutively presenting diabetic patients admitted to the Department of 
Internal Medicine because of foot ulcer, Apelqvist et al.
19
 monitored 314 
patients. Almost half of the patients (54%) healed in 2 months, 19% 
healed in 3 to 4 months, and 27% healed in 5 months. Healing without 
amputation averaged $6664, whereas healing by amputation averaged 
$44,790. Hospitalization costs and topical treatment of ulcers accounted 
for most of the costs. For patients that healed without amputation, 37% 
and 45% of the total costs were for hospitalizations and ulcer treatments, 
and for patients that healed with amputations, 65% of total costs were for 
hospitalizations and 13% for ulcer treatments.
19 
Those patients were 
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treated and followed prospectively long term. A retrospective economic 
analysis was performed of costs for 274 patients during 3 years who 
continued to be part of the study from healing of an initial foot ulcer, with 
or without amputation. Expected total present value cost per patient 
during 3 years of observation was $26,700 (U.S. dollars) for primary 
healed patients with critical ischemia and $16,100 for primary healed 
patients without critical ischemia. For patients who healed with an 
amputation, the corresponding costs were $43,100 after a minor 
amputation and $63,100 after a major amputation.
20 
Another retrospective study of diabetic patients with DFU 
demonstrated an average cost per ulcer episode of $13,179. In this study 
there was an increase in cost according to ulcer depth and severity as 
evaluated by the Wagner classification system.
21
 Costs associated with a 
simple ulcer averaged $1892, and more severe ulcers averaged $27,721. 
This study confirmed the high impact of inpatient stay as being 77% of 
the overall cost. Progression from simple ulcer cases to more complex 
ones carried an additional increase in cost of $20,136.
21 
 Studies that have been published recently demonstrated that the 
economical burden of DFU treatment remains important. Skrepnek et al.
22  
conducted a cross-sectional study utilized Agency for Healthcare 
Research and Quality (AHRQ) Healthcare Cost and Utilization Project 
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(HCUP) National Emergency Department Sample (NEDS) discharge 
records of emergency department cases among persons >18 years with 
any-listed diagnosis of DFU. They recorded 1.019.861 cases of diabetic 
foot complications presented to emergency department in the US from 
2006–2010, comprising 1.9% of the 54.2 million total diabetes cases. The 
mean patient age was 62.5 years and 59.4% were men.
22
 The national cost 
was $1.9 billion per year in the emergency department for diabetic 
patients and $8.78 billion per year (US$) including inpatient charges 
among the 81.2%of cases that were admitted.
22 
Recently Caitlin et al.
23 
analyzed the Nationwide Inpatient Sample 
(2005-2010) using the International Classification of Diseases, Ninth 
Revision codes for a primary diagnosis of diabetic foot ulceration. It was 
demonstrated that for the 336,641 patients who were admitted with a 
primary diagnosis of diabetic foot ulceration (mean age, 62.9 years, 59% 
male, 61% white race) the annual cumulative cost for inpatient treatment 
of DFS increased significantly from 2005 to 2010 ($578,364,261 vs 
$790,017,704; p <0.001). In addition, more patients were hospitalized 
(128.6 vs 152.8 per 100,000 hospitalizations; p < 0.001), and the mean 
adjusted cost per patient hospitalization increased significantly over time 
($11,483 vs $13,258; p < 0.001). Based on multivariable analysis, the 
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main factors contributing to the escalating cost per patient hospitalization 
included increased patient co morbidities, open 
revascularization (unadjusted $15,145 [RI, 1.25] vs adjusted $30,759 [RI, 
1.37]), endovascular revascularization (unadjusted $17,662 [RI, 1.29] vs 
adjusted $28.937 [RI, 1.38]), and minor amputations (unadjusted $9918 
[RI, 1.24] vs adjusted $18,084 [RI, 1.33]) (P < .001, all).
23
  
Even in countries with well organized health system like Canada 
the economical burden remains important negative factor. In Canada in 
the year 2011, DFS was associated with 16,883 hospital admissions 
(327,140 days). This acute institution care represented $320.5 million, 
and with an additional $125.4 million for home care and $63.1 million for 
long term care, the annual cost associated with DFS-related care was 
$547.0 million, or $21.371 annual cost per prevalent case. For an incident 
case of DFS, the average 3-year cumulative cost was $52.360.
13 
Another 
example, is Denmark, in which the median cost for the treatment of a 
DFS patient was estimated 17.900 Euros.
12 
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5. Clinical examination and diagnosis 
 
 
5.1 Etiology 
 
The etiology of DFS in diabetic patients is commonly associated 
with peripheral neuropathy and peripheral arterial disease or both entities, 
therefore each ulcer can be classified as neuropathic (figure 2), ischemic 
(figure 3) or neuroischemic (figure 4). Neuroischaemia is the combined 
effect of diabetic neuropathy and ischaemia, whereby macrovascular 
disease and, in some instances, microvascular dysfunction impair 
perfusion in a diabetic foot.
24 
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Figure 2. Neuropathic ulcer. 
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Figure 3. Ischemic ulcer. 
 
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
34 
 
 
Figure 4. Neuroischemic ulcer. 
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 Peripheral neuropathy 
 
Peripheral neuropathy is the major component of nearly all diabetic 
ulcerations, and may predispose to DFU through its effects on the 
sensory, motor and autonomic nerves.
25
 The loss of protective sensation 
experienced by patients with sensory neuropathy renders them vulnerable 
to physical, chemical and thermal trauma.  This is defined as a level of 
sensory loss that allows patients to injury themselves without recognizing 
neither the injury itself as an event nor infection. In addition, motor 
neuropathy can cause foot deformities (such as hammer toes and claw 
foot), which may result in abnormal pressures over bony prominences. 
This is taking place, when diabetic neuropathy causes atrophy of intrinsic 
musculature of the hand and foot. When this occurs, the extrinsic 
musculature works unopposed causing hammering of the toes and 
retrograde buckling of the metatarsal heads. Thus, both the toes (dorsally) 
and the metatarsal heads (plantary) are more prominent and therefore 
more prone to ulceration. Finally autonomic neuropathy is typically 
associated with dry skin, which can result in fissures, cracking and callus 
which could lead easier to ulcer formation while additionally bounding 
pulses can be often misinterpreted as indicating a good circulation.
26 
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Generally every physician should remember that the presence of 
neuropathy in diabetic patients is associated with a seven–fold increase in 
risk of ulceration.
27 
 
 Peripheral arterial disease. 
 
On the other hand, diabetic patients are twice as likely to have 
peripheral arterial disease (PAD) as those without diabetes.
28
 The 
proportion of patients with an ischemic component to their DFU is 
increasing and it is reported to be a contributory factor in the 
development of DFU in up to 50% of diabetic patients.
26,29  
It is important 
to remember that even in the absence of a poor arterial supply, 
microangiopathy (small vessel dysfunction) also may contribute to poor 
ulcer healing in neuroischaemic DFU.
30
 Decreased arterial perfusion in 
the diabetic foot is a complex scenario and is characterised by various 
factors relating to microvascular dysfunction in addition to macrovascular 
dysfunction.
30 
It is also noteworthy that diabetic patients with the 
sequelae of atherosclerotic disease often present at an earlier stage that 
their counterparts without diabetes. Additionally, diabetic patients often 
have a unique distribution of atherosclerosis at the arterial level. Unlike 
with non-diabetic patients, occlusive disease in diabetic patients has a 
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distinct propensity to occur in the infragenicular vessels in the calf. The 
affected arteries, namely the anterior and posterior tibial and less the 
peroneal artery are more severely affected and are more likely to present 
with occlusion in diabetic patients. Although these arteries are 
preferentially affected, the proximal arteries to the level of the popliteal 
artery are often spared in diabetic patients. Equally important is the 
observation that the dorsalis pedis artery is commonly spared from the 
occlusive disease in diabetic patients.
26,29,30
    
 
Table 1. Typical features of DFU according to the etiology.
31 
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5.2 Assessing the diabetic foot 
 
Patients with a DFU need to be assessed holistically and intrinsic 
and extrinsic factors considered. Patients with DFU should be assessed by 
a multidisciplinary diabetic foot team (MDFT) of physicians within one 
working day of presentation or even immediately in the presence of 
severe infection.
32,33 
However, in reality  in most hospitals,  a MDFT 
approach does not exist and physicians have to work as individuals on 
DFU diagnosis and management.  
Primary health-care physicians should always record the full 
patient history including medication, co morbidities and risk factors for 
DFU and current DM status. They should also take into consideration in 
particular the history of the wound, previous DFU or amputation and any 
symptoms suggestive of neuropathy or PAD.
26 
 
5.2.1 Ulcer documentation 
 
The first clinical step for the physician is to record and document 
the ulcer’s characteristics. Thus the physician has to answer himself 
simple but important questions:
 34
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 Is the wound predominantly neuropathic, ischemic or 
neuroischemic? 
 If ischemic, is there critical limb ischemia? 
 Are there any musculoskeletal deformities? 
 What is the size/depth/location of the wound? 
 What is the color/status of the wound bed? 
               — Black (necrosis) 
               — Yellow, red, pink 
 Is there any exposed bone? 
 Is there any necrosis or gangrene? 
 Is the wound infected? If so, are there systemic signs and 
symptoms of infection (such as fevers, chills, rigors, metabolic 
instability and confusion)? 
 Is there any malodour? 
 Is there local pain? 
 Is there any exudation? What is the level of production (high, 
moderate, low, none), color and consistency of exudation, and is it 
purulent? 
 What is the status of the wound edge (callus, maceration, erythema, 
edema, undermining)? 
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     It is helpful for the physician at the first consultation to digitally 
photograph the diabetic ulcer and periodically thereafter to document 
progress.
35
 This is particularly useful for ensuring consistency of care 
among healthcare practitioners during various examinations, facilitating 
the health in remote areas and illustrating improvement to the patient.
35 
 
5.2.2 Diabetic Neuropathy 
  
As it was described previously, diabetic neuropathy is the major 
component of diabetic ulcer.
25,26,27 
Thus, the consequent vulnerability to 
physical and thermal trauma increase the risk of ulcer formation.  There 
are two simple and one a little more complicated tests which are effective 
in diagnosis of peripheral neuropathy and are commonly used. The first 
two tests are the 10g Semmes-Weinstein  Monofilament (SWM) and the 
tuning fork, and the third one is vibration perception threshold (VPT) 
meter. 
The 10g SWM is the most frequently used screening tool to 
determine the presence of neuropathy in patients with diabetes. It should 
be applied at various sites along the plantar aspect of the foot. Guidelines 
vary in the number of sites advocated, but the international consensus is 
to test at three sites (Figure 5).
36
 A positive result is the inability to feel 
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the monofilament when it is pressed against the foot with enough force to 
bend it. In prospective studies, the SWM identified persons at high risk of 
foot ulceration with a sensitivity of 66-91%, a specificity of 34-86%, a 
positive predictive value of 18-39% and a negative predictive value of 
94-95%.
37,38 
 
 
Figure 5. Procedure for carrying out the monofilament test adapted from 
International Working Group on the Diabetic Foot organization.
36 
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Be aware that patients with small nerve fibre damage and intact 
sensory nerves may have a painful neuropathy. They may describe sharp, 
stabbing, burning, shooting or electric shock type pain, which may be 
worse at night and can disrupt sleep. The absence of cold warm 
discrimination may help to identify patients with small nerve fibre 
damage.
39 
In addition, the physicians should not test for neuropathy the 
patients in areas of callus as this can mask feeling from any of the 
neuropathy testing devices and may give a false-positive result.
 
The conventional tuning fork is also an easy and inexpensive tool 
to assess vibratory sensation. The test is considered positive when the 
patient loses vibratory sensation whereas the examiner still perceives it.
27 
It has been demonstrated that graduated tuning fork (Rydel-Seiffer) fork 
(figure 6) have yielded comparable results to biothesiometer (r=-0.90; 
p<0.001).
40 
 
Figure 6. A modern Rydel-Seiffer fork.
41 
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Finally the VPT meter is another useful valuable instrument to 
assist in clinical evaluation of diabetic neuropathy. It is semi quantitative 
and is potentially less prone to interoperator variation than SWM device. 
The VPT meter also known as Biothesiometer or Neurothesiometer, is a 
handheld unit which is connected by an electrical cord to a base unit 
(figure 7). A mean of three readings measured in Volts (V), is generally 
used to determine the VPT for each foot. In a prospective study, a VPT of 
more than 25 V had a sensitivity of 83%, a specificity of 63%, a positive 
likelihood ratio of 2.2 and a negative likelihood ratio of 0.27 for 
predicting foot ulceration.
42 
 
Figure 7. A modern Biothesiometer or Neurothesiometer.
42 
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In 2001, Bennet M,
43
 at the Chronic Pain Management Service 
(CPMS) at St. James's University Hospital, Leeds developed LANSS 
Pain Scale: the Leeds assessment of neuropathic symptoms and signs. 
This study described the development and validation of a novel tool for 
identifying patients in whom neuropathic mechanisms dominate their 
pain experience which was based on SWM but with the use of 23 gauge 
needle.   
This previous study triggered our Vascular Surgery Department’s 
initiative to conduct a study in our center. The aim of the study was to 
apply the Greek version of the LANSS questionnaire on patients with 
diagnosed neuropathic pain, to assess its validity and investigate any 
association of LANNS with visual analog pain scales (VAS-ADL and 
VAS-INT). Further explanation of the study and visual analog pain scales 
is being undertaken detailed in the results area. 
 
5.2.3 Vascular evaluation 
 
 Medical history of the diabetic patient could be helpful for the 
initial assessment of the PAD presence.
44 
Intermittent claudication is the 
earliest and the most common symptom in PAD and may be present as 
pain, cramping or aching in the calves, thighs or buttocks that appears 
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reproducibly with walking and is relieved by rest.
44 
During clinical 
assessment the physician should always palpate peripheral pulses as a 
routine of the physical examination and include the femoral, popliteal and 
pedal (dorsalis pedis and posterior tibial) pulses.  Assessment of pulses is 
a learned skill and has a high degree of inter-observer variability, with 
high false positive and false-negative rates. The dorsalis pedis pulse is 
reported to be absent in 8.1% of healthy individuals, and the posterior 
tibial pulse is absent in 2.0%. Nevertheless, the absence of both pedal 
pulses, when assessed by an experienced clinician, strongly suggests the 
presence of pedal vascular disease.
45 
The next step in assessing the diagnosis of PAD, is the use of 
Doppler ultrasound measuring the anklebrachial pressure index (ABPI) 
and the Doppler waveform which can be used as adjuncts to the clinical 
findings when carried out by a competent practitioner. Introduced in the 
late 1960s, the measurement of the ABPI is a simple test used to 
document PAD in clinical and scientific settings.
46
 It is the ratio of 
systolic pressures in the lower and upper extremities. Its current 
pathological value is issued from older studies. Ever since, a reduction in 
ABI is used as a strong indicator of PAD, thus ABPI values < 0.9 are 
conventionally used as a pathological threshold to define PAD.
47 
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This decrease in ABPI sensitivity can also be explained by arterial 
stiffness secondary to medial artery calcification (MAC). However, this 
may result in poorly compressible vessels and a high ABPI. Indeed, high 
index values (>1.3-1.4) are particularly frequent in diabetic patients,
48 
 
more specifically when diabetes is concomitant to kidney disease, 
neuropathy or foot lesions.
49
 In this case, high ABI values and MAC 
correlate with the duration and severity of diabetes. Therefore, the 
sensitivity of ABPI seems to be limited in case of complicated or 
longstanding diabetes leading to more MAC. Moreover, high ABPI could 
underestimate the prevalence of PAD in diabetes because ABI values 
between 0.9 and 1.3 would be falsely considered as normal and higher 
values could not be interpreted. In those cases the toe-brachial index 
(TBI) may be useful for the diagnosis of PAD in diabetic patient.  
The American College of Cardiology Foundation (ACCF) and American 
Heart Association (AHA) stated in the ACCF/AHA 2011 guidelines that 
the TBI should be used to establish the lower extremity PAD diagnosis in 
patients in whom the condition is suspected, and when the ABI test is not 
reliable due to non-compressible vessels (longstanding diabetes or 
advanced age).
50
 The evidence supporting this was graded as level B 
evidence. The ACCF/AHA guidelines had defined a TBI <0.7 as 
diagnosis for PAD. 
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Another non-invasive mean of measurement of limb perfusion is 
transcutaneous oxygen tension (normal >40 mmHg). Patients with 
occlusive disease have significantly reduced transcutaneous oxygen 
tension and this has been used to determine the possibility of ulcer 
healing and optimal amputation healing.
51  
In many cases, duplex ultrasound of the leg arteries is useful to 
diagnose the anatomic location and degree of stenosis of PAD in diabetic 
patients.
52
 In many centers, in which a Multi-sliced ct angiography 
(MSCT) angiography is available, although MSCT has not been 
established as a routine screening method for detection of PAD in 
diabetics, it could be used for the detection of anatomical lesions in leg 
ischaemia patients when revascularization is indicated and in those with 
conflicted reports of vascular duplex ultrasound. It is considered as a 
substitute for Magnetic resonance angiography (MRA) for patients who 
have a contraindication for this exam.
52
 MRA is useful in the diagnosis of 
anatomic lesions and the grade of peripheral artery stenosis after a 
functional study with indexes is conducted. Selection of the suitability of 
a lesion for percutaneous revascularization is a second indication for its 
usage. Both indications are applied in peripheral arterial disease subjects 
including diabetic subgroups with IA levels of evidence according to 
AHA/ACC Guidelines.
50 
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Digital subtraction angiography (DSA) is indicated in diabetic 
patients with non-healing ulcers or osteomyelitis requiring endoavascular 
and surgical intervention. Most of these patients, will have severe 
stenotic-occlusive disease involving all three run-off vessels of the calf 
(figure 8). In this patient population, 20% of peripheral bypass grafts will 
have to extend to a pedal artery. The distal anastomosis is either to the 
dorsalis pedis artery or the proximal common plantar artery trunk.
53 
Thus, 
detailed mapping of the arterial disease from abdominal aorta to the pedal 
vessels is necessary. 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
49 
 
 
Figure 8. DSA of below knee arteries with diffused lesions.  
 
 
5.2.4 Identifying infection in a diabetic ulcer 
 
 
Recognizing infection in patients with DFU may be challenging, 
but it has a major role in the patient’s clinical assessment. It is at this 
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crucial early stage that physicians has the potential to curb what is often 
progression from simple (mild) infection to a more severe problem, with 
necrosis, gangrene and often amputation.
54
 Around half of  diabetic ulcers 
(56%) become infected and overall about 20% of patients with an 
infected foot ulcer will undergo a lower extremity amputation.
55 
Thus, a diagnosis of diabetic foot infection should be made using clinical 
signs and symptoms and not just microbiological results. All open 
wounds will be colonized with organisms, making the positive culture 
difficult to interpret. The International Working Group on the Diabetic 
Foot (IWGDF) and the Infectious Disease Society of America (IDSA) 
have developed validated clinical criteria for recognising and classifying 
diabetic foot infection as it is shown in table 2.
56
According to this 
classification there are 4 grades of diabetic foot infection severity; grade 
1 the uninfected, grade 2 mild one, grade 3 moderate one and grade 4 the 
severe one. 
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Table 2. Classification and severity of diabetic foot infection. 
 
 Additionally, accurate diagnosis in the patient with diabetes 
translates to differentiation between bone and soft tissue infection. Thus, 
imaging modalities are useful in this evaluation. A plain radiography (X-
ray) remains the first screening examination on every diabetic patient 
with suspected infection. Both soft tissue edema and cellulitis display 
increased density and thickening of the subcutaneous fat. Infection may 
result in blurring of the usually visible fat planes. Ulcers may or may not 
be visible depending on their size and the orientation. However, the 
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presence of soft tissue swelling, periosteal new bone fracture, cortical 
bone destruction, focal osteopenia and permeative radiolucency are 
diagnostic for osteomyelitis. These osseous changes only become evident 
after osteomyelitis has been present for 10-14 days and require up to 50% 
bone loss before becoming apparent on x-ray.
57 
The sensitivity of the X-
ray ranges 52-93% and specificity 33-92% for the detection of 
osteomyelitis.  On the other hand Computed Tomography (CT) scan is 
superior to X-ray in detection of cortical destruction, periostitis and soft 
tissue or intraosseous gas. Particularly during early stages, these findings 
of acute osteomyelitis may be difficult to detect on plain X-ray, but they 
can be assessed on CT.
58 
However, Magnetic resonance imaging (MRI) is 
presently considered the investigation of choice for diagnosing diabetic 
foot osteomyletis.
59
 In osteomyelitis, the loss of signal in T1-weighted 
images and higher intensity on T2-weighted images can reveal the 
pathology as early as 3 days after infection. A meta-analysis has 
demonstrated MRI is probably the most useful imaging modality for 
assessing osteomyelitis with a sensitivity of about 90% and a specificity 
of about 80%.
60 
There are more diagnostic modalities for diabetic foot infection, 
but they are not available in every centre, they are more expensive and 
they are not used broadly and neither in our University Hospital. Thus 
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there will be no detailed description. These are: Bone scintigraphy (three-
phase bone scan using Technetium-99m-Medronic Acid Bisphosphonate 
provides a two-dimensional image of areas in bone with active bone 
turnover), single photon emission computerized tomography (SPECT) 
(combines bone scan with CT to improve the anatomical–functional 
correlation since it provides three-dimensional images of the foot), White 
blood cell scan (Leukocytes can also be removed from the patient, tagged 
with a radioactive tracer and re-infused into the patient where they 
accumulate at an infected focus), and Positron emission tomography 
(PET scan).
61 
One equally important step to imaging during diagnosis of diabetic 
foot ulcer infection, is the physicians to take appropriate cultures, 
preferably soft tissue (or bone when osteomyelitis is suspected), 
or aspirations of purulent secretions.
56
 Some advocate using a deep 
swabbing technique after the wound has been cleansed and debrided.
62
 In 
some cases superficial swabbing has been shown to be inaccurate as swab 
cultures are likely to grow surface contaminants and often miss the true 
pathogen(s) causing the infection.
56 
In those cases tissue specimens or 
deep swabs should therefore be cultured for both aerobic and anaerobic 
organisms. 
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5.2.5 Identifying foot deformities 
 
As it was mentioned in 5.1, motor neuropathy can cause foot 
deformities (such as hammer toes and claw foot), which may result in 
abnormal pressures over bony prominences. Thus, both the toes (dorsally) 
and the metatarsal heads (plantary) are more prominent and therefore 
more prone to ulceration (figure 9).
25,26,27,56  
 
 
 
Figure 9. Prominent areas to ulceration due to diabetic foot deformities. 
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Additionally, these patients may also develop atypical walking 
patterns (Figure 10). The altered biomechanical loading of the foot can 
result in callus, which increases the abnormal pressure and can cause 
subcutaneous haemorrhage.
36 
One clinical condition with diabetic foot 
deformity is Charcot joint and should be immediately diagnosed. Charcot 
joint is a form of neuroarthropathy that occurs most often in the foot and 
in people with diabetes.
63
 Nerve damage from diabetes causes decreased 
sensation, muscle atrophy and subsequent joint instability, which is made 
worse by walking on an insensitive joint. In the acute stage there is 
inflammation and bone reabsorption, which weakens the bone. In later 
stages, the arch falls and the foot may develop a ‘rocker bottom’ 
appearance (figure 10). 
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Figure 10. Patients had developed atypical walking patterns, resulting in 
infected ulcer and gangrene. 
 
5.2.6  Classification of diabetic foot ulcer 
 
 
Diabetic foot ulcer is without doubt an important social-
economical burden worldwide. Therefore, various wound classification 
systems have been developed, so there will be a common ‘language’ 
among the physicians who are involved in the diabetic foot management.  
Classification systems grade ulcers according to the presence and extent 
of various physical characteristics, such as size, depth, appearance and 
location. These systems can help in the planning and monitoring of 
treatment and in predicting outcome.
62,64
 and also for research and audit. 
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Classification systems should be used consistently across the healthcare 
team and be recorded appropriately in the patient’s records.  
One well-established system widely used is the new University of 
Texas (UT) diabetic wound classification system (figure 11).
65 
According 
to this classification there are 4 stages depending on the presence of 
infection or/and ischemia combined with 4 grades of wound state.  
 
 
Figure 11. University of Texas (UT) diabetic wound classification 
system.
65 
 
 
A more comprehensive scoring system for an infected diabetic 
ulcer could help clinicians determine the need for hospitalization, the 
urgency of undertaking diagnostic tests or surgical interventions, and the 
type and route of antimicrobial therapy. Thus, Lipsky et al.
66 
developed a 
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diabetic foot infection (DFI) wound score system (Table 3) that 
incorporates grading of both a wound’s measurements and specific 
parameters related to local and systemic signs and symptoms of infection. 
They have used data obtained from patients enrolled in SIDESTEP 
(Study of Infections in Diabetic feet comparing Efficacy, Safety and 
Tolerability of Ertapenem versus Piperacillin/tazobactam) with a diabetic 
foot infection, which was a randomized, multicenter, antibiotic treatment 
trial.
67 
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i. 
Item Assessment Preassigned scoring 
Wound parameters   
Purulent discharge Absent 0 
 Present 3 
Other signs and symptoms 
of inflammation 
Absent 0 
Nonpurulent discharge Mild 1 
Erythema Moderate 2 
Induration Severe 3 
Tenderness   
Pain   
Local warmth   
Range of wound 
parameter (10-item) 
subtotal 
 0-21 
Range of wound 
parameter (eight-item) 
subtotal 
 0-15 
Wound measurements   
Size (cm2) <1 0 
 1–2 1 
 > 2–5 3 
 > 5–10 6 
 > 10–30 8 
 > 30 10 
Depth (mm) <5 0 
 5–9 3 
 10–20 7 
 > 20 10 
Undermining (mm) <2 3 
 2–5 5 
 >5 8 
Range of wound 
measurement subtotal 
 3–28 
Range of total 10-item 
DFI wound score 
 3–49 
Range of total eight-item 
DFI wound score 
 3–43 
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ii. 
 
Table 3. i) 10 item DFI, ii) Details and explanation of DFI items.  
 Recently the Society for Vascular Surgery Lower Extremity 
Guidelines Committee undertook the task of creating a new classification 
of the threatened lower extremity. Risk stratification is based on three 
major factors that impact amputation risk and clinical management: 
Wound, Ischemia, and foot Infection (WIfI) (Table 4). 
68
i. 
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ii) 
 
iii) 
 
 
 
Table 4. i) Wound score. ii) Ischemia score. iii) foot infection score. 
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One more classification system to categorize and define diabetic 
ulcer objectively and facilitate communication between health-care 
providers, was developed by the IWGDF. Diabetic ulcers are classified 
according to five categories: perfusion, extent/size, depth/tissue loss, 
infection and sensation; the Perfusion, Extent, Depth, Infection and 
Sensation (PEDIS) classification system (which is mentioned in table 
4).
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6. Strategy for diabetic foot ulcer management 
 
 The IWGDF had previously published practical guidelines for the 
prevention and management of diabetic foot ulcer in 2011,
36,56
 and 
recently the IWGDF Editorial Board produced an updated summary 
guidance for daily practice. The resultant of this process, after review by 
the Editorial Board and by international IWGDF members of all 
documents, is an evidence-based global consensus on prevention and 
management of foot problems in diabetes.
70 
 Nowadays, it has been clear that diabetic foot ulcer is a matter of a 
multidisciplinary team that should be consisted by a number of specialists 
such diabetologist, vascular surgeon, orthopedic surgeon, general 
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surgeon, dermatologist, specialized nurse, phycologist and every 
physicians that could help in the diabetic foot treatment.  
 
6.1 Principles of ulcer treatment 
 
6.1.1 Pressure relief and protection of the ulcer 
 
 Mechanical off-loading – the cornerstone in ulcers 
with increased biomechanical stress  
 Total contact casting or other casting techniques – 
preferable in the management of plantar ulcers 
 Temporary footwear 
 Individually moulded insoles and fitted shoes 
 Non-weight bearing 
 limitation of standing and walking crutches, etc. 
 
6.1.2 Restoration of skin perfusion 
 
 Peripheral arterial disease is the most important factor relating to 
the outcome of a diabetic foot ulcer. Healing will be severely 
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impaired in diabetic patients with a foot ulcer in case of symptoms 
or signs of ischemia, and a low ABPI or TBI. 
 The benefits of pharmacological treatment to improve perfusion 
have not been established. 
 Emphasis should be placed on cardiovascular risk reduction 
(cessation of smoking, treatment of hypertension and 
dyslipidaemia, use of aspirin). 
 
            However there is still debate on if someone has always to 
revascularize patients with diabetic ulcer with open procedure or 
endovascular one or even treat them conservatively. In a recent 
systematic review studies appeared to demonstrate improved rates of 
limb salvage associated with revascularization compared with the 
results of conservatively treated patients in the literature. Nevertheless, 
there were insufficient data to recommend one method of 
revascularization over another.
71 
 
            There are also supporters of the direct revascularization 
according the angiosomes concept. Briefly, the foot can be divided 
into six angiosomes (Figure 12): three arising from the posterior tibial 
artery, one from the anterior tibial artery, and two from the peroneal 
artery. The anterior tibial artery supplies the dorsal side of the toe and 
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dorsal foot; the posterior tibial artery supplies the plantar side of the 
toe, web space of the toes, plantar foot, and the inside of the heel; and 
the peroneal artery supplies lateral ankle and the outside of the heel. 
For intervention, we first confirmed the location of nonhealing 
ulceration/gangrene and the angiosome-based favorable target lesion 
by digital subtraction angiography and then we are undertaking the 
procedure.
72 
 
 
 
 
Figure 12. The foot can be divided into six angiosomes: three arising 
from the posterior tibial artery, one from the anterior tibial artery, and two 
from the peroneal artery. 
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 However, there is always the conservative treatment even for 
revascularization. There are diabetic patients with ischemic foot ulcers 
not available for revascularizations that are not though excluded from 
healing without major amputation.
73 
 
 
6.1.3 Treatment of infection 
 
 
 Superficial ulcer with skin infection 
 Cleanse, debride all necrotic tissue and surrounding callus 
 Start empiric oral antibiotic therapy targeted at S.aureus and 
streptococci. 
 
 Deep (potentially limb-threatening) infection 
 Urgently evaluate for surgical drainage to remove necrotic tissue, 
including infected bone, and drain abscesses 
 Consider need for arterial revascularization 
 Initiate empiric, parenteral broad-spectrum antibiotic therapy 
aimed at Gram-positive and Gram-negative bacteria, including 
anaerobes. 
 
 Metabolic control and treatment of co morbidities. 
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 Optimal diabetes control, if necessary with insulin (blood glucose 
<8 mmol/L or <140mg/dL) 
 Treatment of edema and malnutrition 
 
 Local wound care 
 Frequent wound inspection 
 Frequent wound debridement (with scalpel) 
 Control of exudation and maintenance of moist environment 
 Consideration of negative pressure therapy in postoperative 
wounds 
 
 There are treatments which are not established in routine 
management: 
 Biological active products (collagen, growth factors, bio-
engineered tissue) in neuropathic ulcers 
 Systemic hyperbaric oxygen treatment 
 Silver or other anti-microbial agents containing dressings 
 
 
6.1.4 Education of patients and their social environment 
 
 
Instruction should be given on appropriate self-care and on how to 
recognize and report signs and symptoms of (worsening) infection such 
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as fever, changes in local wound conditions, or hyperglycemia. Both 
group and individual training approaches could increase foot care self-
efficacy in the patients with DM.
74 
 
6.1.5 Determining the cause and preventing recurrence 
 
 
The cause of the ulceration should be determined in order to reduce 
the chance of recurrences. Ulcers on contra-lateral foot should be 
prevented and heel protection provided during periods of bed rest. Once 
the episode is over, the patient should be included in a comprehensive 
foot care program with life-long observation. 
 
7. Psychosocial implication and quality of life in 
patients with diabetic foot ulcer 
 
During last decade the medical society has been focused on the 
social-economical and psychological impact of diabetic foot ulcer on 
patients. Along with increased morbidity, foot ulcers can lead to lifelong 
disability and may substantially diminish the quality of life (QOL) for 
these patients.
75
 Specifically, patients with diabetic foot ulcers have 
restrictions on mobility, poor psychosocial adjustment, and lower self-
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perceptions of health than patients who do not have ulcers.
75,76
 An 
understanding of the specific effects of chronic diabetic foot ulcers on 
individual patients’ QOL is central to the direction of treatment, 
management of compliance, and patient/practitioner communication. 
Brod et al.
75
 conducted focus groups with patients with foot ulcers and 
reported that ulcers had a negative impact on almost every aspect of 
QOL, including psychological, physical, social and economic 
functioning. For example, approximately 50% of patients indicated that 
they were no longer employed because of their foot ulcers, and many 
patients reported that their dependence on others placed a strain on their 
relationships with members. 
The Diabetic Foot Ulcer Scale (DFS) was developed to measure 
the impact of diabetic foot ulcers on QOL issues most important to 
patients. The DFS was also translated into several languages using 
both forward and backward translations and cognitive debriefing to 
ensure cultural equivalence. The DFS contains a total of 64 items, 58 of 
which are used to compute 15 QOL subscales.
77
 The six remaining items 
address employment-related issues and are not included in computation 
of subscale scores on the DFS long form.  
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The final version of the DFS-SF (short-form)
78
 which is used 
broadly contains a total of 29 items grouped into six subscales:  
 
- Leisure (5 items)  
- Physical health (5 items)  
- Dependence/daily life (5 items)  
- Negative emotions (6 items)  
- Worried about ulcers/feet (4 items)  
- Bothered by ulcer care (4 items)  
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Part B 
1. Aim of the study 
 
Primary aim:  
 
To assess the impact of various associated factors on the healing process 
in diabetic foot ulcers. 
 
Secondary aims: 
 
i. To conduct a survey in order to highlight the current trends in the 
management of diabetic foot among Vascular Specialists practicing in the 
Mediterranean region. 
 
ii. To apply the Greek version of the LANSS questionnaire on patients 
with diagnosed neuropathic pain, to assess its validity and investigate any 
association of LANNS with visual analog pain scales (VAS-ADL; 
activities of daily living and VAS-INT; pain intensity). 
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iii. To apply the WiFI and 10-item DFI classification systems and 
correlate them with any other factor which is associated with wound 
healing and limb loss. 
 
iv. To apply the Diabetic Foot Ulcer Scale Short form of the Greek 
version which was developed to measure the impact of diabetic foot 
ulcers on QOL issues most important to patients. 
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2. Methodology 
 
An observational study of 103 diabetic patients with foot ulcer 
being followed up for 12 months. 
 
ΙNCLUSION CRITERIA 
 
 DM type 2 
 Foot ulcer 
 Age > 18 years 
 
EXCLUSION CRITERIA 
 
 Malnutrition ( BMI < 18 ) 
 Immobility ( bed or wheel chair bound or stroke limb ) 
 Pharmaceutical immune-suppression ( steroids or recently 
transplantation ) 
 Patient without disposing capacity in their past medical history 
(such as schizophrenia, Alzheimer disease, et al)  
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
91 
 
 Unable to read and write Greek 
 
A common protocol was completed for every patient during first 
examination. 
 
 Date of first examination and every other one that followed.  
 The place that they live (city, suburbs or village).The 
occupation that they have (labor or office work) and what is 
their supporting family environment. 
 The Body mass index (BMI), their height and weight. 
 The level of self care such as: 
Self examination times per week 
Foot washing times per week 
Foot hydration times per week 
Cutting their nails 
If they wear any special shoes 
If they walk barefoot 
 Which doctor referred him to our department , how many 
times , and to which other specialties 
 Time interval between the ulcer and the referral  
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 Cause of ulcer (shoe trauma, cutting nails trauma, unknown, 
other cause) 
 History of claudication, previous ulcer, previous vascular 
intervention, previous amputation. 
 Family history of coronary artery disease (CAD), DM and 
PAD 
 Texas Wound Classification of the ulcer 
 10-items DFI classification of the ulcer 
 WiFI classification of the ulcer 
 Past medical history of hypertension (HT), hyperlipidemia 
(HL), CAD, atrial fibrillation (AF), DM and its duration, 
chronic renal disease (CRD),  chronic obstructive pulmonary 
disease (COPD), cerebro-vascular disease (CVD), alcohol or 
tobacco use. Whether the patient has stopped or restarted 
smoking. 
 If the patient is on antiplatelet, statin, insulin, other 
medication for DM, vitamin K antagonist or any new oral 
anticoagulants. 
 Blood tests:  
Haematocrit (Hct), Haemoglobin (Hb), White blood cells 
(Wbc) and their type (Nutrophilic or Lymphocytes), platelets 
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(PLT) number, mean platelet volume (MPV), Erythrocyte 
Sedimentation Rate (ESR), c-reactive protein (CRP), 
creatinine (CR), Urea (Ur), sodium (Na) and potassium (K), 
Aspartate Aminotransferase (AST or SGOT), Alanine 
Aminotransferase  (ALT or SGPT), Creatine phosphokinase 
(CPK), lactate dehydrogenase (LDH), Billirubin ( 
direct/indirect ) ,  International Normalized Ratio (INR) , 
Prothrombin time (PT) , partial thrombopalstin time (APTT), 
low density lipoprotein (LDL) , high density lipoprotein 
(HDL) , Cholesterol , triglycerides, HbAc1 (hemoglobin A1c 
test). 
 Clinical examination with palpable pulses of femoral, 
popliteal, posterior tibial and dorsalis pedis arteries and 
ABPI 
 Antibiotics therapy 
 Cultures from the ulcer 
 LANSS scale of each patient 
 VAS ADL and VAS INT 
 Imaging with foot X-ray, DSA (angiosomes that are related 
with the ulcer), CTA or MRA 
 Any minor or major amputation 
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 Vascular intervention open or endovascular one 
 Post-op ABPI 
 Any new medication 
 Any new referral to other specialty 
 Completion of Diabetic Foot Ulcer Scale Short form of the 
Greek version. 
 
During re-examination, a re-evaluation of each patient was 
undertaken and an individualized re-examination was decided afterwards. 
 
Primary Outcomes: 
 
 Healed ulcer during 12 months 
 Unhealed ulcer during 12 months 
 Major or minor amputation during 12 months 
 Death during 12 months 
 
Additionally: 
 A survey with SurveyMonkey 
(https://www.surveymonkey.com/)  was conducted from 
December 2013 to November 2014, including 10 main 
questions on the management of diabetic foot patients. The 
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questionnaire was sent to Vascular Specialists included in 
the current mailing list of the Mediterranean League of 
Angiology and Vascular Surgery. Spearman’s correlation 
analysis was used for statistical analysis. This section is 
explained thoroughly in the published paper which is part of 
the results. 
 A prospective instrument validation study of LANSS was 
conducted in University Hospital of Larissa, on 70 patients 
(35 NP and 35 nociceptive pain), from April 2015-June 
2015. Visual analog pain scales (VAS-ADL; impact of pain 
on daily living activities, VAS-INT; pain intensity) were 
also assessed and correlated with LANSS scale. This section 
is explained thoroughly in the published paper which is part 
of the results. 
 The Diabetic Foot Ulcer Scale Short form of the Greek 
version was answered by 103 diabetic patients that were 
treated in our department. Every patient answered this form 
during the first examination with the presence of foot ulcer, 
and then they answered after either the healed ulcer or the 
minor amputation or the major amputation or after a year 
even with their ulcer unhealed.  
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Part C 
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I. Spanos K, Lachanas V, Karathanos C, Poredos P, Hussein E, 
Giannoukas AD. A survey on the status of the management of diabetic 
foot in the Mediterranean region. Int Angiol. 2015 Feb 13. [Epub ahead 
of print] 
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ABSTRACT  
Aim: We conducted a survey in order to highlight the current trends in 
the management of diabetic foot among Vascular Specialists practicing in 
the Mediterranean region. 
Methods: A survey Monkey was conducted from December 2013 to 
November 2014, including 10 main questions on the management of 
diabetic foot patients. The questionnaire was sent to Vascular Specialists 
included in the current mailing list of the Mediterranean League of 
Angiology and Vascular Surgery. Spearman’s correlation analysis was 
used for statistical analysis. 
Results: The response rate was 37.5% (150/400) and 52.6% of them were 
practicing in a Tertiary hospital service. The diabetic foot patient 
management and most of the amputations were performed in Tertiary 
hospitals. Most responders were experienced vascular specialists (55.3%). 
In general specialists with high work volume performed more major 
amputations in diabetic patients as compared to PAD patients and 
adopted equally all types of interventions (open, endovascular and 
hybrid). In particular the most experienced specialists required more 
diagnostic investigations, performed more minor amputations and used 
endovascular approach as first line treatment in diabetic patients. A lack 
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of multidisciplinary approach was demonstrated as referral to other 
specialties was suboptimal. 
Conclusion: In the Mediterranean region, patients with diabetic foot are 
managed by the most experienced vascular physicians in Tertiary centers. 
Endovascular first approach seems to be the preferred strategy, but 
services were able to provide open as well as hybrid procedures. Finally, 
the multidisciplinary team approach has not been adopted as part of the 
standard care even in tertiary centers.  
 
Key words: Diabetic foot, multidisciplinary team, amputation. 
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Introduction 
 
Foot infection in patients with diabetes mellitus (DM) remains an 
important issue with chronic and highly disabling complications 
associated with high risk of limb loss.
i
 
The most common presentation of diabetic foot infections (DFIs) 
usually is associated with an ulcer that occurs from trauma as a 
consequence of peripheral sensory and motor neuropathy. Various 
microorganisms inevitably colonize the wound and very often one or 
more species grow in the wound, which may lead to tissue damage and 
inflammation.
2
DFIs impose a major economic burden and cost is 
increased disproportionately to the severity of the condition. The 
treatment of DM and its complications in the United States generated at 
least $116 billion in direct costs of which at least 1/3 of them were linked 
to the treatment of DFIs.
3
Additionally, DFI is the leading cause of non-
traumatic lower limb amputations in the world, resulting in an amputation 
risk that is approximately 40 times greater than that of the general 
population 
2 
and most of them are preceded by foot ulceration.
4
 Thus, 
prevention and treatment strategies of DFIs are of paramount importance.  
However, there is lack of nation-wide formal primary care-based diabetic 
foot service around the world, and focused research is still needed to 
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confirm that such service in the diabetic community is effective in terms 
of prevention and cost-effectiveness.
5
  
As far as the treatment of DFIs is concerned, selective 
revascularization strategies are advocated, either using open procedures 
as the initial approach or endovascular therapies that have acquired an 
important role in current practice with promising results.
6,7,8 
However, 
treatment of many patients is not in line with current guidelines and there 
is a wide variation among countries and centers. The Eurodiale study 
suggested that guidelines were too general and that healthcare 
organizational barriers and personal perceptions resulted in underuse of 
recommended therapies.
9
 
This survey was conducted under the guidance of the 
Mediterranean League of Angiology and Vascular Surgery (MLAVS) to 
highlight what are the current trends in the management of diabetic foot 
in the Mediterranean region. 
 
 
 
Methodology 
An internet survey using Survey Monkey system
10
, which is an 
online survey software, was conducted. A questionnaire (Table 1) having 
10 questions covered the following domains; domain 1: physicians’ 
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related practice (questions 1,2), domain 2: physicians’ clinical practise 
(questions 3,4,5,6), domain 3: physicians’ treatment methods (questions 
7,8,9), domain 4: physicians’ co-operation with other specialties 
(questions 10).  Question 3 was divided in 3 sub-questions depending on 
the type of pathology treated by the individual physician. Likewise 
question 9 was further divided in 3 sub-questions depending on 
intervention used in the treatment (open, endovascular or hybrid). 
The questionnaire was sent through the mailing list of the MLAVS. 
Invitation was send to vascular specialists practicing in Mediterranean 
and Southern European countries (Egypt, Italy, Lebanon, Portugal, 
Serbia, France, Greece, Bulgaria, Cyprus, Romania, Croatia, Slovenia, 
Algeria, Turkey, Israel and Tunisia). The period of survey was 12 months 
(from 12.2013 to 11.2014). After the first invitation, nine more reminders 
were sent in order to raise the attention of interested physicians and to 
achieve a decent response rate. Data was extracted by the software of the 
service of Survey Monkey. Spearman’s correlation analysis was 
performed by using the SPSS 20 statistical software (IBM, Chicago, IL, 
USA).  P values lower than 0.05 were considered as statistically 
significant.  
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Results 
The questionnaire was sent to 400 vascular specialists. The 
response rate was 37.5% (150/400). The vast majority of responders were 
experienced vascular specialists practicing for more than 25 years in the 
field (55.3%) (Figure 1). About half of participants were practicing in a 
Tertiary centre (University hospital service, 52.6 %), while the remaining 
ones were practicing in various types of hospital (regional, general or 
private) (Figure 2).  
Spearman's correlation coefficient rho (rs) showed that, hospital 
type was correlated significantly with: the management of both diabetic 
(rs=.202, p < 0.05) and non-diabetic PAD patients (rs=.240, p < 0.01), and 
with amputation rate (minor [rs=.340, p < 0.01] and major [rs=.335, p < 
0.05]). More specifically, University Hospitals dealt with more patients 
(diabetic and non-diabetic) and undertook more amputations.  
The experience of the vascular specialists was significantly 
correlated with the management of patients with critical limb ischaemia 
(CLI) (rs=.260, p < 0.01), vascular investigations (rs=.162, p < 0.05), 
minor amputations (rs=.208, p < 0.05) and endovascular interventions 
(rs=.187, p < 0.05) in diabetic patients. Along these lines, specialists with 
experience more than 25 years, handled more CLI patients, requested 
more vascular investigations for the diagnosis of diabetic patient, 
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proceeded in more minor amputations and preferred endovascular 
interventions as first line treatment approach.  
As it is showed on figure 3, the specialist had to manage diabetic 
patients with more complicated clinical presentation, such as diabetic 
neuropathy (74.15%), gangrene (52.38%) and ulcer (46.94%). 
Furthermore, specialists that were treating higher number of diabetic 
patients, performed more major amputations (rs=.278, p<0.01) and used 
all the armament of interventions (open [rs=.335, p<0.01], endovascular 
[rs=.314, p<0.01] or hybrid [rs=.282, p<0.01]. 
In the diagnosis, specialists used mostly duplex scan (70.95%), 
Ankle Brachial Index (ABPI, 51.35%) or Digital Subtraction 
Angiography (DSA, 50.68%), (Figure 4). Physicians who requested more 
diagnostic investigations, were those who routinely examined less the 
patient for the presence of foot neuropathy before the intervention (rs=-
.173, p < 0.05). Indeed, only 60% (86/146) of the vascular specialists 
considered important to evaluate the diabetic foot for the presence of 
neuropathy before the treatment. 
Those vascular specialists opting either endovascular first or open 
first approach were dealing in their services with the wide spectrum of 
vascular patients including diabetic and non-diabetic. Physicians in favor 
of endovascular first approach as treatment option performed more minor 
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(rs=.343, p < 0.01) and major (rs=.398, p < 0.01) amputations, as 
compared to the ones in favor of open interventions who performed 
only major amputations but at a lower percentage (rs=.228, p < 0.05). 
Vascular specialists who used hybrid procedures performed low numbers 
of amputation (minor or major).  
Finally, the multidisciplinary approach model to patients with 
diabetic foot was poor as it is displayed in figure 5. The specialists tended 
to refer their patients to a Cardiologist in 68.09%), to a rehabilitation 
centre in 46.81%, while referral to ophthalmologist, podiatrist, 
dermatologist and physiotherapist was not part of the routine in the 
standard daily practice. 
Discussion 
Over the last 30 years, consensus documents have been produced 
and practical guidelines have been published for the management of 
diabetic foot both in National and Worldwide level.
1,2,11,12,13,14,15 
The St. 
Vincent Declaration was the first attempt in 1989 to set targets for the 
treatment of diabetic patients and the quality level of diabetes care in 
Europe.
11 
Recently the Infectious Diseases Society of America (IDSA) in 
USA,
2
 the Italian Societies of Diabetes in Europe
1
 and the International 
Working Group on the Diabetic Foot (IWGDF) worldwide
14
 have 
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published updated practical guidelines for the diabetic foot  management. 
Thus, while the multidisciplinary approach in the treatment is required 
the organization of such service is still unsettled in daily clinical practice. 
Along this line, we decided with our survey to highlight what is the 
current status in the management of diabetic foot in the Mediterranean 
region.  
There is a geographic variation in the management of diabetic 
patients and their amputation rates are related to regional differences in 
the utilization of inpatient services.
16 
In our survey, most of the 
amputations were performed in tertiary hospitals, probably because 
diabetic foot is by far one of the worse complications in diabetic patients 
requiring dedicated vascular services that may not be available in small 
size hospitals in the Mediterranean region.
 17
 This is supported further by 
the fact that even in the tertiary hospitals specialists involved with the 
treatment of diabetic foot were more experienced among their colleagues.  
The other important trend that was demonstrated in our survey, was 
the fact that the senior specialists with >25 years of experience, preferred 
endovascular approach as first option for revascularizing the diabetic 
foot. This strategy has been adopted from various centers as a reasonable 
one regardless the degree of vascular pathology because of these patients’ 
co-morbidities.
18
 However, vascular services involved in the management 
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of diabetic foot patients had expertise in both endovascular and surgical 
skills (open, endovascular and hybrid). It is of note that in our survey 
hybrid procedures were associated with lower rate of amputations. This is 
supported by several recent publications which present optimistic and 
positive results of hybrid procedures in the management of critical limb 
ischemia.
 17,19, 20,21 
This reiterates that vascular services treating diabetic 
foot  should be able to  apply all types of interventions to optimize the 
outcomes.
6,21 
In our survey, the first line diagnostic approach was duplex scan, 
followed by ABPI and DSA while useful diagnostic tools, such as toe-
brachial pressure index (TBI) and the TcPO, in this category of patients 
who have uncompressible arteries, were scarcely implemented. While 
ABI has been recognized as a powerful tool for the detection of 
peripheral arterial disease not only in most epidemiological studies but 
also in diabetic patients
22,23,24
  surprisingly it was underused by the 
vascular specialists responded to our survey. This practice contradicts 
with the IWGDF guidelines
17
  that suggest in addition to a thorough 
assessment of history for symptoms of arterial insufficiency, all patients 
with a diabetic foot ulcer should undergo hand-held Doppler evaluation 
of both pedal pulses,  measurement of ABI and, in cases of diagnostic 
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uncertainty, measurement of toe-brachial index (TBI) or transcutaneous 
pressure of oxygen (TcPO2).
17
 
The other noticeable finding  in our survey, was   that only 60% of 
the Vascular physicians considered as important to evaluate the patients 
with a diabetic foot for the presence of peripheral neuropathy before the 
treatment, although it is known  that this can predict
 
the risk of 
developing a diabetic foot ulcer or higher rate of amputation.
25
 
 
Finally, in our survey it was demonstrated that most of the vascular 
physicians had not adopted a multidisciplinary approach in the 
management of patients with diabetic foot as a routine in daily practice. 
The referral to Cardiologist was at the level of 60% but it was not within 
the standard strategy to seek advice from a podiatrist, ophthalmologist, 
physiotherapist and in case of amputation to refer the patient for 
rehabilitation. This finding shows clearly that at least in the 
Mediterranean region the multidisciplinary approach of diabetic foot 
patients is not part of the standard care, despite the fact that this type of 
approach can result in significant reductions in total and 
major amputations rates.
26,27 
Therefore, it appears that reorganization of 
the service provided to diabetic patients is of paramount importance in 
the healthcare system of the Mediterranean countries. 
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Finally, it should be acknowledged that our study may be inherent 
of some potential limitations. Firstly the response rate was 37.5%, which 
means that our results may not absolutely representative for the entire 
Mediterranean region. This is aggravated by the fact that our results were 
not analyzed with regard to the national origin of the physicians. Also, we 
considered for granted that all patients were under the care of an 
endocrine-internal medicine physician. Nevertheless, besides these 
limitations, we still think that our survey provides a valuable snapshot on 
the current status regarding the management of diabetic foot patients in 
the Mediterranean region and our findings reiterate those reported in 
several other studies.
1,2,4,7,8,9,17,18,19,20,21
 
 
 
Conclusion 
In the Mediterranean region, patients with diabetic foot are 
managed by the most experienced vascular physicians in Tertiary centers. 
Endovascular first approach seems to be the preferred strategy, but 
services were able to provide open as well as hybrid procedures. Finally, 
the multidisciplinary team approach has not been adopted as part of the 
standard care even in tertiary centers.  
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Question 1 In what kind of hospital do you work? 
Question 2 What is your clinical experience? 
Question 3 What kind and how many patients do 
you treat per months?: (more than one 
answers) 
Question 4 What is the most usual pathology of the 
diabetic patients in your Department?: 
(more than one answers) 
Question 5 What is (are) your preferable vascular 
investigation(s) before intervention in 
diabetic patients with ulcer?: (more than 
one answers) 
Question 6 Do you evaluate routinely the presence 
and the severity of neuropathy?: 
Question 7 How many minor amputations do you 
perform every year per 100 treated 
diabetic patients? 
Question 8 How many major amputations in 
diabetic patients do you perform every 
year? 
Question 9 What is the method of your preference 
to revascularize patients with ischemic 
diabetic foot?: (more than one answers) 
Question 10 Do you refer the patients routinely to a: 
(more than one answers) 
 
Table 1. Survey Monkey Questions. 
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Figure 1. Question 2. 
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Figure 2. Question 1 
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Figure 3. Question 4 (Diabetic vasculopathy: Diabetic vasculopathy with or without ulcer, 
pain without skin: pain without skin lesion) 
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Figure 4. Question 5 (Toe-brachial: Toe-brachial index, Ankle brachial: Ankle brachial index, 
TCPO2 :  transcutaneous oxygen pressure, CTA: computed tomography angiography, MRA: 
magnetic resonance angiography, DSA: digital subtraction angiography) 
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Figure 5. Question 10. (Rehabilitat: Rehabilitation physician)  
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Abstract 
Introduction: One of the diagnostic tools of neuropathetic pain (NP) 
relies on screening questionnaires including the Leeds Assessment of 
Neuropathic Symptoms and Signs (LANSS) questionnaire. 
Aim: To validate the LANSS questionnaire in Greek population. To 
assess any correlation between LANSS score and visual analog pain 
scales. 
 
Methods: A prospective instrument validation study of LANSS was 
conducted in University Hospital of Larissa, on 70 patients (35 NP and 35 
nociceptive pain), from April 2015-June 2015. Visual analog pain scales 
(VAS-ADL; impact of pain on daily living activities, VAS-INT; pain 
intensity) were also assessed and correlated with LANSS scale. 
Results: The mean age of NP and nociceptive pain group was 
67.11±10.05 and 39.14±17.07 years respectively. The mean LANSS 
score was 12.84 (± 9.27) in initial test, and 12.54 (± 9.41) in the retest 
evaluation. Cronbach’s alpha was 0.895 and 0.901 at initial and retest 
examinations respectively, both values indicating good internal 
consistency. NP group had significant higher LANSS score than 
nocipeptive pain group (21.34 [± 1.39] vs 4.34 [± 4.86], p < 0.01). The 
sensitivity of LANSS questionnaire to distinguish neuropathic and 
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nociceptive pain was 94.29% (95% CI: 80.81-99.13%), while its 
specificity was 88.57 % (95% CI: 73.24-96.73 %).  
A significant correlation was noticed between total LANSS score and 
VAS-ADL (initial r: 0.248; p < 0.05 and retest evaluation r: 0.288; p < 
0.05). 
Conclusion: The LANSS score is a reliable and valuable instrument to 
assess neuropathic pain in diabetic patients and to differentiate it from 
nociceptive pain in Greek population. In diabetic patients LANSS score is 
associated with impact on daily activities and potentially with quality of 
life. 
 
Key words: diabetic neuropathic pain, nocipeptive pain, LANNS score, 
validation. 
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Introduction 
 
Peripheral neuropathy is characterized by diffused damage to the 
peripheral nerve fibres. The commonest cause of peripheral neuropathy is 
diabetes, and 30–90% of those patients with diabetes develop peripheral 
neuropathy.
1
 Neuropathic pain (NP) is a well-known complication 
involving one-third of all diabetic patients.
1
 It has a huge effect on a daily 
quality of life, both physically and mentally.
2
 Thus, the symptoms of NP 
can be debilitating and cause sleep disturbances, anxiety and interfere 
with physical functioning.
3 
For this purpose, simple assisting instruments 
have been developed such as 10 cm visual analog scale which can easily 
and fast assess the impact of pain on activities of daily living (VAS-ADL) 
(0-10) and the pain intensity (VAS-INT) (0, no pain; 10, unbearable 
pain).
4,5
  
The diagnosis of NP relies on the clinical presentation and the 
existence of co morbidities of the patient and on screening 
questionnaires.
6,7
 Generally there are many types of categorization of 
pain, and one notably useful categorization has been the division in 
nociceptive pain versus NP. Nociceptive pain is provoked after neural 
pathways’ activity caused by physical damage of the tissue or potentially 
traumatic-tissue related stimuli.
8
 Although the differential diagnosis of 
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NP is not formidable, it requires time and the acquisition of special 
diagnostic skills. To simplify this task, there are a number of diagnostic 
instruments, including the Leeds Assessment of Neuropathic Symptoms 
and Signs (LANSS) questionnaire which emerges for its suitability.
9
  
The LANSS questionnaire has been already validated in Turkish,
10
 
Brazilian,
5
 Chinese,
11
 Portuguese,
12
 and Greek.
13
 The use of validated 
translations of questionnaires helps to compare populations of different 
countries and cultures, which helps to establish protocols for global 
health. The aim of the present study was to apply the Greek version of the 
LANSS questionnaire on patients with diagnosed NP, to assess its 
validity and investigate any association of LANNS with visual analog 
pain scales (VAS-ADL and VAS-INT).
 
 
Material and Methods 
 
Study design and data collection 
 
We have conducted a prospective study in the University Hospital 
of Larisa, from April 2015 to June 2015. The inclusion criteria were: 1. 
Patients suffering from pain for 1 or more days (persistent and/or 
recurrent pain) 2. Education level: high school degree or above, be able to 
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understand Greek 3. Patients should have one of the following 
neuropathic or nociceptive pain diseases: Neuropathic pain: Diabetic 
patients with peripheral neuropathy. Nocipeptive pain: Orthopedic non-
diabetic patients with bruises, sprains, bone fractures, arthritic disorders 
and myofascial pain due to abnormal muscle stress. 
Patients were enrolled only after confirmation by 2 pain clinicians with 
consistent diagnosis. The exclusion criteria were: 1. Patient without 
disposing capacity in their past medical history (such as schizophrenia, 
Alzheimer disease, et al) 2. Unable to read and write Greek 3. Patients 
with mixed pain. 
The LANSS scale is comprised by a total of seven items including 
five questions regarding presentation of pain and two diagnostic items 
involving sensory tests for the presence of allodynia and decreased 
sensation to pinprick.
9
 A 23-gauge needle was used for pinprick test in 
contact with the patient’s skin. If a pinprick was not felt in the area, the 
syringe was mounted onto the needle to increase the weight on the 
patient’s skin. Hyperalgesia was considered to be present in cases in 
which the pinprick test was leading to an exaggerated painful response on 
the symptomatic area being compared with the normal one. Allodynia 
was also considered to be present when pain or unpleasant sensation was 
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provoked by lightly stroking cotton wool across the painful area and 
when normal sensation was experienced in the nonpainful site. 
Patients’ replies to the questions were a “yes or no” type and were 
evaluated differently depending upon the question. For this purpose we 
used the Greek validated LANNS questionnaire.
13 
Additionally, patients were asked to answer a 10 cm visual analog 
scale for the impact of pain on daily living activities of (VAS-ADL) (0-
10) and a 10 cm visual analog scale for the pain intensity (VAS-INT) (0, 
no pain; 10, unbearable pain) at their first visit to the outpatient clinic. 
VAS-ADL represents a glimpse of quality of life of the patients while 
VAS-INT the overall perception of the patient for the intensity of pain.
5
 
A LANSS score ≥ 12 was classified as neuropathic pain, and a score < 12 
was classified as nociceptive pain.
9
 Retesting of the patients was 
performed within 2 weeks after initial evaluation. 
Since there is no widely established a theoretical basis for 
determining sample size or power calculation in questionnaires 
psychometric validation,
14
 we have used the general rule of thumb for our 
sample size calculation. According to this rule, the minimum 
recommended participants size is between 5 and 10 times the number of 
questionnaire items.
14
 In our study we have considered the 5 to 1 ratio of 
participants to items for the sample size calculation of every group, thus 
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we recruited 35 consecutive patients with neuropathic pain from diabetic 
foot clinic and vascular surgery department and 35 consecutive patients 
with nociceptive pain from orthopedic department. 
The study was approved by the University Hospital of Larissa 
review board. An approval has been obtained from the copyright holder 
for the use of LANNS questionnaire. 
 
Data analysis 
 
Internal consistency of the Greek LANNS questionnaire was 
evaluated by applying Cronbach’s alpha test with a minimum acceptable 
value of 0.7.
15 
Test–retest reliability was evaluated by analysing the 
correlation between LANNS scores (total and score of each item) of the 
first visit at the outpatient clinic (test), and the retesting of the patients by 
using the Pearson’s correlation coefficient. Furthermore, Bland-Altman 
plot was used to assess agreement between test and retest evaluations. 
         The validity of the questionnaire was demonstrated by examining 
the correlation between LANNS scores and the type of pain (Spearman’s 
correlation coefficient), by comparing total scores between neuropathic 
and nociceptive pain groups with the Mann–Whitney U test, and by 
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assessing the sensitivity and specificity of LANNS for detecting 
neuropathic and nociceptive pain. 
Furthermore, correlations between LANNS scores and the VAS-
ADL as well as the VAS-INT were explored (Spearman’s correlation 
coefficient), and the VAS-ADL and VAS-INT scores between 
neuropathic and nociceptive pain groups were compared with the Mann–
Whitney U test. 
Data analysis was performed using the SPSS 20 statistical software 
(IBM, Chicago, IL, USA).  P values lower than 0.05 were considered as 
statistically significant.  
 
Results 
 
Neuropathic pain group consisted of 35 patients (28.6% female) 
with a mean age of 67.11±10.05 (range 49 – 85) years. Nociceptive pain 
group consisted of 35 patients (37.1% female) with a mean age of 
39.14±17.07 (range 18 – 77) years. 
LANSS questionnaire, VAS-ADL and VAS-INT were fully 
completed by all patients in their initial visit as well as in their retesting 
evaluation. 
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The mean LANSS score was 12.84 (± 9.27) in the initial test, and 
12.54 (± 9.41) in the retest evaluation. Cronbach’s alpha was 0.895 and 
0.901 at initial and retest examinations respectively, both values 
indicating good internal consistency. All correlations between test and 
retest evaluation were significant (P<0.01 level) for the total score and all 
LANSS items (Table 1). Bland-Altman Plot (Figure 1) showed that the 
95% limits of agreement ranged from −2.768 to 2.968, while almost all 
differences were located between the agreement thresholds.” 
 
LANSS score was strongly correlated with the type of pain in both 
test (r: 0.896; p < 0.01) and retest (r: 0.893; p < 0.01) evaluations. The 
mean LANSS scores of the neuropathic and nociceptive pain groups were 
21.34 (± 1.39) and 4.34 (± 4.86) in the first evaluation and 21.34 (± 1.34) 
and 3.74 (± 4.30) in the retesting respectively. Neuropathic pain group 
had significant higher LANSS scores (p < 0.01). The sensitivity of 
LANSS to distinguish neuropathic and nociceptive pain was 94.29% 
(95% CI: 80.81-99.13%), while its specificity was 88.57 % (95% CI: 
73.24-96.73 %).  
A significant correlation was noticed between total LANSS score 
and VAS-ADL in both initial (r: 0.248; p < 0.05) and retest evaluation (r: 
0.288; p < 0.05); while there was no significant correlation between total 
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LANSS score and VAS-INT in both initial (r: 0.044; p = 0.716) and retest 
evaluation (r: 0.029; p < 0.814). VAS-ADL was significant higher in 
neuropathic pain group (p < 0.05), while no significant difference was 
noticed in VAS-INT between the two groups. 
 
Discussion 
 
The neuropathic pain differs from nociceptive pain both in etiology 
and clinical presentation.
1,2,8
 The early diagnosis and treatment is crucial 
for better prognosis especially in diabetic patients, who develop 
complications such as diabetic foot.
16
 However, current existing 
examinations, such as nerve conduction velocity and somatosensory 
evoked potential, do not have high specificity.
11
 Quantitative sensory 
testing with high specificity requires expensive equipment,
17
 while skin 
biopsy is not easily accepted by patients due to its traumatic feature. 
Physicians should be able to use tests and examinations with high 
sensitivity and specificity to diagnose neuropathic pain with a minimum 
cost. Therefore, many neuropathic pain questionnaires have been 
developed in recent years. 
NP questionnaires are efficient diagnostic tools for differential 
diagnosis of neuropathic pain 
5,6,7,9,10,12,13 
Even those physicians who have 
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a little experience about neuropathic pain, they can easily use them in 
their practice to diagnose NP.
7
  Additionally, most NP questionnaires 
have high sensitivity and specificity, they do not require special 
equipment or examinations, and they maintain the cost low. Thus, NP 
questionnaires are highly efficient and cost effective.
6
 
 Until recently in Greece, no questionnaire for NP had been 
validated. The Douleur Neuropathique 4 (DN4) was the first 
questionnaire that was validated in Greek, for diagnosis of NP and 
showed good potential as discriminatory tool of neuropathetic element of 
pain.
18
Besides, during last years in Greece, physicians’ efforts have been 
escalating to translate in Greek and validate various questionnaires 
concerning other specialties
19,20,21
 aiming  to play an important role in 
epidemiological studies and to establish the incidence of various 
pathologies. 
The internal consistency of the Greek translation of LANSS
13
 was 
analyzed in our study.  Internal consistency measures how efficiently the 
scores for the individual items of the instrument correlate with each 
other.
22 
The minimum acceptable value for Cronbach’s alpha test to 
represent and evaluate internal consistency is 0.7.
15 
In our study, 
Cronbach’s alpha was 0.895 and 0.901 at initial and retest examination 
respectively, both values suggesting very good internal consistency of the 
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Greek LANSS. Those rates were according to the line or even higher than 
previous reports
5,10,11,12 
( Cronbach’s alpha values 0.67-0.824) even when 
being compared with the study which translated, adapted and validated 
the Greek LANSS questionnaire at first place.
13 
Test-retest reliability shows stability of calculated scores with 
repeated testing and can be assessed by correlating initial test and 
subsequent retest scores.
22 
In our study, correlations of test-retest 
evaluation were statistically significant for total LANSS score as well as 
for questionnaires’ items.  Similar correlations have been reported from 
other countries.
 11,12
 
Validity is the degree to which an instrument measures what it is 
supposed to measure.
23
 In other words, it is the ability of an instrument to 
distinguish between patient groups who have or do not have the disease 
being studied. In our study, validity of the Greek version of the 
questionnaire was assessed by examining the correlation between 
LANNS scores and the type of pain, by comparing total scores between 
neuropathic and nociceptive pain groups, and by assessing the sensitivity 
and specificity of LANNS for detecting neuropathic and nociceptive pain. 
The Greek LANSS proved to be a valid instrument, since total score was 
strongly correlated with the type of pain; neuropathic pain group had 
significant higher LANSS scores; while the sensitivity and specificity of 
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were 94.29% and 88.57% respectively. This has been also been proven in 
the Batistaki et al.
13 
study, although the sensitivity rate was lower and 
specificity rate was higher (82.76% and 95.24% respectively). Those 
percentages are according to the line with previous reports that have 
shown similar or ever lower rates of sensitivity and specificity between 
NP and LANNS score and have been used as important diagnostic tool in 
other countries.
5,10,11,12
 
In our study, it was shown that there was a significant correlation 
between LANNS score and VAS-ADL while there was no such relation 
noticed for VAS-INT. Thus patients with higher LANNS score (in our 
case diabetic patients), answered that their pain had a greater impact on 
daily living activities, although the severity of the pain (VAS-INT) did 
not differ from that of patients with nociceptive pain.  Thus, NP may have 
a great impact on quality of life of diabetic patients and their daily 
activities, although this phenomenon is not always associated with the 
intensity of the pain. Schestatsky et al. (2011) have demonstrated similar 
results supporting the negative role of NP on daily activities in diabetic 
patients.
5
 In addition, there have been many reports previously which 
have showed that NP of diabetic foot impacts significantly the diabetic 
patients’ quality of life.3,24,25  
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Besides the value of LANNS score questionnaire is useful for every 
physician in the diagnosis of NP, it may play an important role in 
epidemiological studies, aiming to establish the incidence of neuropathic 
pain in various countries.
26 
 
There are some limitations in our study. Even though there is no 
widely established theoretical basis for determining sample size or power 
calculation in questionnaires psychometric validation,
14
 our sample size is 
relative small compared to the other LANSS validation studies
5,11,12
. We 
have also excluded patients with mixed pain so that our two study groups 
will be more homogenous and give more accurate results. This is also a 
limitation, since it could imply a bias of our study. One other potential 
limitation inherent in our study is the difference in the mean age between 
patients with NP and nociceptive pain. Nevertheless, it has not been 
reported any significant association among patients with NP or 
nociceptive pain and age.
1,2,3,6,8
 Finally, although we did not assess the 
impact of NP on quality of life with validated questionnaires, VASs have 
provided us a short information about the influence of NP on diabetic 
patients’ daily activity, which consists a rough approach of quality of life.   
 
Conclusion
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The LANSS score is a reliable and valuable instrument to assess 
neuropathic pain in diabetic patients and to differentiate it from 
nociceptive pain in Greek population. In diabetic patients LANSS score is 
associated with impact on daily activities and potentially with quality of 
life. 
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Table 1.  Test-retest reliability for LANSS questionnaires.  
 
 Test-Retest Reliability 
 Pearson’s correlation 
coefficients between 
scores of test and retest 
LANSS questionnaires 
LANSS total score 0.937
**
 
1
st
 Question of LANSS 0.970
*
 
2
nd
 Question of LANSS 0.913
*
 
3
rd
 Question of LANSS 0.913
*
 
4
th
 Question of LANSS 0.971
*
 
5
th
 Question of LANSS 0.912
*
 
6
th
 Question of LANSS 0.990
*
 
7
th
 Question of LANSS 0.972
*
 
 
* P<0.01 
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Figure 1: Bland-Altman Plot: The 95% limits of agreement ranges from −2.768 to 
2.968. 
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Abstract:  
A prospective non-randomized cohort study on consecutive diabetic 
patients with foot ulcer was undertaken, to assess factors associated with 
the healing process or limb salvage, and evaluated the impact of their 
treatment on their quality of life (QOL). QOL was evaluated using 
diabetic foot ulcer scale-short form questionnaire (DFS-SF) before and 
after treatment. A total of 103 diabetic patients with ulcer (mean age 
69.7±9.6 years, 77% male) were treated and followed up for 12 months. 
Ulcer healing, minor amputation and major amputation rates were 41, 41 
and 18%, respectively while mortality rate was 18%. Ulcer healing was 
associated with University of Texas wound grade I and the SIDESTEP 
trial’s diabetic foot infection wound score.  Limb loss was associated with 
non-palpable popliteal artery, longer in-hospital stay and delay until 
referral. QOL was improved in all domains of DFS-SF (p<0.0001) 
throughout the cohort of our patients regardless of their outcome and no 
outcome (healing, minor or major amputation) was superior to other. 
Significant improvement was observed in all domains of hygiene self-
management after consultation during follow up period. 
  
Key words: Diabetic foot; ulcer; quality of life; limb loss. 
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Introduction 
The International Diabetes Federation (IDF) reported that the 
global prevalence of diabetes (DM) in adults was 8.3% in 2013 expecting 
to rise beyond 592 million by 2035 with a 10.1% global prevalence.
1 
One 
of the most insidious complications of DM is foot ulcer (DFU) and 
according to the World Health Organization (WHO), all  foot 
complications may be encompassed under  the term diabetic foot 
syndrome defined as “ulceration of the foot associated with neuropathy 
and different grades of ischemia and infection.”2 DFU was always a 
multinational burden and in recognition of this reality the St. Vincent 
Declaration in 1989 included a set of goals for the health care of people 
with DM.
3 
In response to the emerging pandemic of DM type 2, after this 
declaration,  several other regional partnerships between the IDF and 
WHO, proceeded with their own declarations such as: the Declaration of 
the Americas or DOTA (1996),
4 
the Western Pacific Declaration on 
Diabetes (WPDD 2000)
5
 and the Declaration and Diabetes Strategy for 
Sub-Saharan Africa (2006).
6  
Various wound classification systems have been developed, so 
there will be a common ‘language’ among the physicians and a helpful 
tool in the planning and monitoring of treatment and in predicting the 
outcome of ulcer healing and assessing the associated factors.
 7,8,9,10,11 
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Many practical guidelines have been published with most recent one the 
evidence-based global consensus for the prevention and management of 
diabetic foot by the International Working Group on the Diabetic 
Foot (IWGDF) Editorial Board.
12
 
Along with increased morbidity, foot ulcers can lead to lifelong 
disability and may substantially diminish the quality of life (QOL) for 
these patients.
13
 Specifically, patients with DFU have restrictions on 
mobility, poor psychosocial adjustment, and lower self-perceptions of 
health than patients who do not have ulcers.
13,14
 An understanding of the 
specific effects of DFU on individual patients’ QOL is central to the 
direction of treatment, adherence to treatment, and patient/practitioner 
communication. 
The aim of this observational study was primarily to assess the 
factors associated with the healing process or limb salvage in diabetic 
patients with foot ulceration. We also evaluated the impact of treatment 
and QOL outcomes.   
 
Methods 
A prospective non-randomized cohort study on consecutive 
diabetic patients with foot ulceration was undertaken in a Mediterranean 
country (Central Greece, an area with mainly agricultural production) by 
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a tertiary centre which has the only existing foot clinic service in the 
region. These were patients with DM type 2 suffering from lower limb 
ulceration who were referred to our service either at the outpatient clinic 
or as an emergency. Exclusion criteria were: i) malnutrition (body mass 
index: BMI< 18), ii) immobility (bed or wheel chair bound or stroke 
limb), iii) immune-suppression, and, iv) lacking mental capacity to 
consent to the study.  
The patients were under close follow up since their first assessment 
and had regular appointments in the outpatient clinic of our service 
depending on their ulcer healing progress. On the first visit, 
demographics (age, sex, height, weight, body mass index-BMI) and 
personal details (residence address, occupation, carer identity) and the 
past medical history, including duration of DM, history of hypertension 
(HT), hyperlipidemia (HL), coronary artery disease (CAD),  atrial 
fibrillation (AF), peripheral artery disease (PAD),  chronic kidney disease 
(CKD), chronic obstructive pulmonary disease (COPD), cerebrovascular 
disease (CVD), ophthalmopathy, history of smoking and alcohol, 
antiplatelet and statin therapy were  recorded. Additionally, family 
history of HT, HL and DM was also recorded.  
In addition, all patients received clinical assessment by a Vascular 
Surgeon, including  palpation of the peripheral arteries, Ankle brachial 
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index (ABI) measurement, ulcer evaluation and a recording of self-
management hygiene (self-examination, foot washing, foot hydration, the 
way of cutting their nails, walking barefoot and usage of special 
anatomical shoes). Ulcer evaluation was undertaken according to three 
grading systems: i) the University of Texas wound classification which is 
a system for diabetic foot wounds that evaluates wound depth, the 
presence of infection, and peripheral arterial occlusive disease in every 
category of the wound assessment,
9 
ii) the diabetic foot infection (DFI) 
wound score based on SIDESTEP trial (Study of Infections in Diabetic 
feet comparing Efficacy, Safety and Tolerability of Ertapenem versus 
Piperacillin/tazobactam) with the measurement of 10-items,
10
 and, iii) the 
Society for Vascular Surgery developed a Lower Extremity Threatened 
Limb Classification System in which the risk stratification is based on 3 
major factors that impact amputation risk and clinical management such 
as wound, ischemia and foot infection (WIfI).
11 
The goal of all these 
systems is to improve communication, leading to a less complex, more 
predictable treatment course and, ultimately, an improved result. 
Additionally, neuropathic pain (NP) was also assessed using 
LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale 
questionnaire.
15
 Patient replies to the questions were a “yes or no” type 
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and were evaluated differently depending upon the question. For this 
purpose we used the Greek validated LANSS questionnaire.
16 
Since this is an observational study, each Vascular Surgeon could 
decide on the diagnostic investigations needed [foot X-Ray, Duplex scan, 
Computed Tomography Angiography (CTA), Digital Subtraction 
Angiography (DSA)] and on the type of treatment (open surgery, 
endovascular, hybrid procedures or conservative).  Primary outcomes 
were ulcer healing and minor or major amputation. Analysis of the factors 
associated with the primary outcomes was undertaken. Secondary 
outcomes were the impact in QOL after each type of treatment and self-
management at 12-month follow up.  
A multidisciplinary approach program was established in our 
hospital regarding these patients.  
Regarding the assessment of patient QOL, we used the Greek 
version of Diabetic Foot Ulcer scale- short form (DFS-SF) as translated 
by Mapi Research Trust-All (Copyright © 2015 rights reserved).17 The 
DFS was developed to measure the impact of diabetic foot ulcers on QOL 
issues most important to patients. The DFS was also translated into 
several languages using both forward and backward translations and 
cognitive debriefing to ensure cultural equivalence. The DFS contains a 
total of 64 items, 58 of which are used to compute 15 QOL subscales.
18
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The 6 remaining items address employment-related issues and are not 
included in computation of subscale scores on the DFS long form.  
The final version of the DFS-SF (short-form)
17 
which is used 
broadly contains a total of 29 items grouped into six subscales:  
- Leisure (5 items)  
- Physical health (5 items)  
- Dependence/daily life (5 items)  
- Negative emotions and worried about ulcers/feet (10 items)   
- Bothered by ulcer care (4 items)  
 Thus, each patient had to fill the DFS-SF questionnaire during the 
first examination, and after 12 months of follow up. Also, the QOL was 
analyzed in respect to the ulcer treatment, the patient’s residence and the 
level of their home care. Additionally, Visual Analogue Scales for the 
impact of pain on daily living activities of (VAS-ADL) (0–10) and a 10 
cm visual analog scale for the pain intensity (VAS-INT) (0, no pain; 10, 
unbearable pain)
15 
were recorded at their first visit to the outpatient clinic 
and their last one. 
This study involved the collection of existing data and diagnostic 
tests that have been recorded in such a manner that subjects could not be 
identified, either directly or through identifiers linked to the subject. 
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However, the protocol and informed consent were approved by the 
Institutional Review Board. 
 
Statistical analysis 
The relationships of categorical variables and the main outcomes 
observed (ulcer healing, minor amputation, major amputation, mortality) 
was examined with the use of the Chi Square statistic, while the 
relationships between main outcomes and continuous measurements was 
assessed with the independent samples t-test or the Mann Whitney test, 
where appropriate. The findings were assessed and the statistically 
significant variables were entered in a binary logistic regression model. 
The two way interaction effects were also considered to reach the final 
model for each outcome.  For the change in the Quality of life Measures 
the Paired samples t-test was applied for each of the dimensions 
measured. Statistical significance was set at 0.05 (two-sided). The 
analysis was carried out with the use of SPSS v.21.0   
 
Results 
 Over a period of 2 years (2012-2014) 103 consecutive patients with 
diabetic foot ulcer entered into the study and were followed up for 12 
months. Only 2 patients were already excluded due to the exclusion 
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criteria. The mean age of the patients was 69.7±9.6 years and most of 
them were males (76.7%, 79/103). More than half of the patients were 
manual workers and almost everyone was cared for by family members. 
The population was overweight with mean BMI of 28. Most of the 
patients were on antiplatelet (80%) and statin (70%) therapy, while half 
of them were also on insulin. Social-demographics, past-medical history 
details and blood test results are presented in table 1. 
 Almost half of the patients (47%, 49/103) presented directly to our 
hospital as an emergency, while 20% (21/103) were referred by an 
endocrinologist, 11.5% (11/103) by a general surgeon, 11.5% by a 
general practitioner (GP), 3.8% (4/103) by another vascular surgeon, 3% 
(3/103) by an internal medicine physician, 2% (2/103) by a nephrologist, 
1% (1/103) by a neurologist and 1% (1/103) by an orthopedic department. 
The mean time until referral to our service was 23.8±9 days. There was 
no difference between patients with self-referral and physician referral. 
However, there was a seasonal variation in the presentation and referral 
of these patients to our service peaking in colder months during the year 
(autumn and winter, 64%, 66/103 vs spring and summer 36%, 37/103, p< 
0.05). The most common cause of ulcer was trauma (lack of attention 
68%, 70/103; shoe wearing trauma 11.7% ,12/103); after great saphenous 
harvesting 2% (2/103); after nail cutting 1% (1/103); and 17.5% (18/103) 
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by unknown cause. The ulcers were confined mainly to toes (64%, 
66/103), and less frequently to the shin (9.7%, 10/103), the sole (7.8%, 
8/103), the heel (7.8%, 8/103), the dorsal surface of the foot (5.8%, 
6/103), the ankle (2.9%, 3/103) and in a previous amputation stump area 
(1.9%, 2/103) (Figure 1). 
 In table 2 patients are categorized according to the University of 
Texas wound classification system (i) and according to the Lower 
Extremity Threatened Limb Classification System (WIfI) (ii). 
Additionally, the mean DFI wound score was 20.4±3, while the mean 
LANSS score was 20.5±3.4 (all patients in our study had LANSS score > 
12).  
During 12 month of follow up, 41% (42/103) of the patients had 
their ulcer healed. From this group, 40.5% (17/42) of the patients were 
healed in the first month, 85.7% (36/42) in first 3 months and 97.6% 
(41/42) in first 6 months. A further 50.5% (52/103) of the patients 
underwent a minor amputation, 63% (33/52) of which during first 
hospitalization, 88.5% (46/52) during first 3 months and 98% (51/52) 
during first 6 months after initial presentation. All but 9 patients achieved 
healing of their minor foot amputation. These 9 patients along with 
another 9 underwent major amputation accounting for a 17.6% (18/103) 
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
156 
 
limb loss. Most of the amputations (14/18, 77%) were undertaken in first 
6 months.   
 After multiple logistic regression analysis including characteristics 
of tables, referral characteristics and ulcer location and causes, ulcer 
healing was associated with University of Texas wound classification and 
DFI wound score.  Patients with TEXAS grade I ulcer had 23-fold more 
often ulcer healed (95% CI 2.3-220, p=0.007) than those with a higher 
grade. Additionally, after increase of one DFI score unit, the odds risk for 
ulcer non-healing is increased by 15% (95% CI 1.5-30%, p=0.028), with 
mean DFI score 17±2 for ulcer healed patients and 24.5±3 for non-healed 
patients. (Figure 2) 
 Minor amputation was associated with Texas classification, COPD 
and LANSS score. Patients with TEXAS grade II or higher had 11.3 
increased odds risk for minor amputation (95% CI 3.4-38, p<0.001) than 
those with grade I. Additionally, patients with COPD had 12.3 increased 
odds risk for minor amputation (95% CI 2.1-73 p=0.006), while for every 
increase of one unit of LANSS score the odds risk for minor amputation 
is increased by 43% (95% CI 2-100%, p=0.040). (Figure 3) 
 Major amputation was associated with palpable pulses of popliteal 
artery, hospital stay and time until referral. Every patient with non-
palpable popliteal artery had 5.2 increased odds risk for major amputation 
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(95% CI 1.03-26 p=0.045). For each additional hospital stay the odds risk 
for a major amputation increased by 8% (95% CI 2-14% p=0.007).  
Finally, for each additional day of delay until referral the odds risk for 
major amputation increased by 3.5% (95% CI 1-6% p=0.011). 
 Among patients with evidence of ischemia requiring 
revascularization, no differences were observed in respect to healing rate, 
minor and major amputation according to the type of intervention; 36 
patients underwent 38 procedures: 20 endovascular only, 9 open only and 
9 hybrid ones and the total healing rate was 30.5% (11/36). In patients 
who were not considered candidates for revascularization (67/103), a 
reasonable healing rate was observed (46%, 31/67). 
Lack of multidisciplinary assessment was observed in a large 
number of patients and therefore during their initial hospitalization they 
were referred for evaluation to other services: 65 (63%) patients to 
Endocrinology for DM control, 34 (33%) to Cardiology, 8 (7.7%) to 
Nephrology, 8 (7.7%) to Ophthalmology, 6 (5.8) to Orthopedics, 4 (3.8) 
to a Chest Medicine and 1 (1%) to Neurology.  
 The mortality rate was 17.5% (18/103) during the 12 month period. 
Myocardial infraction (MI) accounted for the majority of deaths (72%, 
13/18), while 3 patients died because of severe sepsis and 1 due to acute 
renal failure. After multivariate analysis only age was associated with 
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death. For each one additional year of age, the risk of death was increased 
by 17% (95% CI 7 -29% p=0.001).  During 12-month follow up no 
patient had a development of a new ulcer or a deterioration of a healed 
one. 
All alive in 12 month-follow up patients completed the QOL 
questionnaire (DFS-SF) in their first and the last assessment (12-month 
follow up); 82.5% (85/103) were available for QOL assessment at 12-
month follow up. QOL was significantly improved in all domains of 
DFS-SF (p<0.0001) throughout the cohort of our patients after their 
treatment as compared with their condition before treatment. (Table 3) In 
addition, after further analysis, it appeared that the improvement of QOL 
was not associated with the type of treatment and the outcome, thus there 
was no difference in improvement of QOL among patients regardless of 
whether they had their ulcer healed or had undergone an amputation. The 
lower improvement in QOL was demonstrated in domains related to 
physical health (mean increase 9.9), dependency in daily life (mean 
increase 10.9), treatment satisfaction (mean increase 12.4) and higher 
improvement in domains related to leisure (mean increase 16.5) and 
negative emotions (mean increase 18.2). Finally, when QOL was 
analyzed according to the patient residency area and the caring person, no 
correlation was identified. A significant improvement was observed in all 
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
159 
 
domains of hygiene self-management between the first and the last 
assessment (12 months) of follow up while VAS of both types were 
improved significantly during follow up.(Table 4) 
 
Discussion 
 
 In our study, the mean duration of DM among patients was 18 ±3 
years. However, it was demonstrated that their actual awareness about the 
nature of the disease was inadequate. Thus, 50% of our patients presented 
to our service late from the onset of the ulcer (mean time 24 days), with a 
poorly controlled DM (mean Hb1AC: 8.1% and BMI: 28) and low 
awareness of hygiene self-management (table 3). It has been previously 
demonstrated that foot self-care is generally infrequent, and clinical 
monitoring in outpatient clinics is performed for less than half of diabetic 
patients with foot ulcers.
19 
In practice, patient education aiming to 
promote foot care knowledge and self-examination is advocated by most 
experts and guidelines as an important strategy to prevent diabetic foot 
complications. Education of patients at high risk of or with ulceration is 
considered to be particularly important.
20 
In some trials, foot care 
knowledge and self reported patient behavior seem to be positively 
influenced by education in the short term.
21
 In our study after many 
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consultations of our patients during follow up, they managed to improve 
their hygiene self-management status considerably (Table 4), decreasing 
the likelihood of a new ulcer. However, the effect of patient education is 
still in doubt and there is insufficient robust evidence that limited patient 
education alone is effective in achieving clinically relevant reductions in 
ulcer and amputation incidence.
21 
Additionally, in our study, almost half 
of the patients had a late referral by their physician, and thus it would 
seem advisable to implement strategies oriented towards the improvement 
of primary care physician awareness of diabetic foot and its 
complications, along the IWGDF recommendations that healthcare 
professionals should receive periodic education to improve the care of 
high-risk individuals.
12
  It is true that such patients may neglect 
themselves because of various reasons including impaired sensation due 
to neuropathy, impaired vision as a result of retinopathy, and other co-
morbidities including cardiac and renal impairment which all may 
contribute also to the lack of a personal alarm system.
22,23
    
It is still debatable whether ulcer healing in diabetic patient always 
requires revascularization. Although, in a recent systematic review, it was 
demonstrated that improved rates of limb salvage were associated 
with revascularization compared with the outcomes of conservatively 
only treated patients, there were insufficient data to recommend one 
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method of revascularization over another.
24 
Along this line, in our study, 
no differences were observed in respect to healing rate, minor and major 
amputation according to the type of intervention. However, this was an 
observational study and not designed to compare those treatments. Over 
the last decade, there has been a marked shift from open revascularization 
to an endovascular one in diabetic patients with foot ulcer
25
and in some 
centers endovascular treatment is used first as "preliminary approach" for 
critical limb ischemia and diabetic foot.
26 
Additionally, in patients who 
were not considered candidates for revascularization, a reasonable 
healing rate was observed (46%, 31/67). Recently, it was suggested that 
even diabetic patients with ischemic foot ulcers not available for 
revascularization, should not be excluded from healing without major 
amputation.
27 
The SIDESTEP trial has demonstrated that the clinical response 
was less favorable at the follow-up assessment in patients with a DIF 
score >19.
10 
Along this line, our study showed that patients with healed 
ulcer had a score of mean value 16.8 (figure 2). Another important factor 
that was associated with ulcer healing was the TEXAS classification 
during first examination. Thus, it seems that initial clinical evaluation 
with the use of DFI score and TEXAS classification may help physicians 
to identify which patients are at increased risk for non-healing ulcers or 
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
162 
 
even limb loss, and in whom closer follow up and more aggressive 
treatment may be indicated. 
 
 
As far as the predictive factors associated with limb loss are 
concerned, it has been previously demonstrated that male gender and the 
presence of neuropathy,
28
 Severity of Diabetic Foot Infection,
29
 elevated 
fasting blood sugar,
30
WBC and PAD,
31
are associated with amputations. 
In our study, Texas classification, COPD and LANSS score were 
associated with minor and delay of hospital referral, the severity of PAD, 
and the prolonged hospitalization were associated with major amputation. 
It seems that detailed initial clinical assessment and fast-track 
management of DFU are important factors associated with limb loss. 
Furthermore, it is of note that the majority of deaths in our cohort were 
cardiac related. This underlines the importance of cardiovascular disease 
risk factor control as primary prevention in patients with DM 2 as it has 
been recommended from the American Heart Association and the 
American Diabetes Association.
32 
 The evaluation of the patient QOL has been recognized as an 
important area of scientific knowledge, since the concept of QOL has 
been related to the notion of health: satisfaction and well-being in the 
physical, psychological, socio-economic and cultural spheres.
33
 
According to the WHO, QOL can be defined as an individuals’ 
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perception of their position in life in the context of the culture and value 
systems in which they live in and in relation to their goals, expectations, 
standards and concerns.
34 
Studies have evaluated and reported on QOL in 
diabetic patients with ulcer and compared them with other control 
groups.
13,34-38
 Presence or history of diabetic foot ulceration has been 
proved to have a large impact on physical functioning and 
mobility.
38
Diabetic foot ulcer patients had much worse health related 
QOL (HRQL) compared with the diabetes population and the general 
population, especially in physical health.
13, 36-38 
Our study is the first to 
our knowledge that evaluates the QOL in the same group of patients 
before and after treatment. Thus, in our study the presence of diabetic 
foot ulcer was associated with poor QOL, and QOL was significantly 
improved in all domains of throughout the cohort of our patients after the 
ulcer management. However, it was interesting, that QOL was improved 
regardless of patient outcome (healing, minor or major amputation) and 
no outcome was superior to another. Similarly, VASs were improved 
after treatment in our cohort. Even in cases that a major amputation was 
undertaken, the patients perceived their situation as improved in terms of 
QOL. A recent report was in agreement with that outcome, suggesting 
that clinicians should not assume that patients will experience poorer 
QOL outcome only because they underwent an amputation.
34 
An 
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
164 
 
understanding of the specific effects of chronic diabetic foot ulcers on 
individual patient QOL is central to the direction of treatment, 
management of compliance, and patient/practitioner communication. 
Patients with a diabetic foot ulcer should to be assessed 
holistically, thus intrinsic and extrinsic factors should be addressed and 
managed by a multidisciplinary diabetic foot team (MDFT) of physicians 
as soon as possible (within one working day of presentation or even 
immediately in the presence of severe infection).
12,39,40 
However, in many 
hospitals not only in our country, but also in the Mediterranean region,
41
 a 
MDFT approach has not been adopted and physicians have to work as 
individuals on diagnosis and management and attempt to refer patients to 
other specialties when they consider that it is necessary. Studies, have 
demonstrated that the introduction of a MDFT has been associated with a 
reduction in the incidence of major amputations in patients with DM.
 42,43 
Potential selection and treatment biases may exist as about 50% of 
patients had PAD, because this study was a prospective observational 
one, in patients referred to the Vascular Service of a tertiary Hospital. 
However, this reflects the real world practice of a Vascular Service which 
inevitably is committed to deal with more difficult-to-heal ulcers.  
 
Conclusions  
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Our observational study showed that delayed hospital referral, 
prolonged hospitalization and absence of popliteal pulses were associated 
with limb loss. Additionally, initial clinical status assessment with DFI 
score and TEXAS classification may predict ulcer healing. QOL 
improved in all patients after treatment regardless of the outcome (healing 
or amputation). Also, improvement was observed in the hygiene self-
management.   
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Figure 2. After increase of one DFI score unit, the risk for ulcer non-healing is increased by 
15% (95% CI 1.5%- 30%, p=0.028), with mean DFI score 17±2 for ulcer healed patients and 
24.5±3 for non-healed patients (DFI: diabetic foot infection; CI: confidence interval) 
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Socio-Demographics Past medical history Blood test  
Sex 
76.7% Males 
(79/103) 
Type of Diabetes 100% Type 2    Mean±SD 
Age in years 69.7±9.63 
Mean duration of 
DM in years 
17.7±7.9  Hb  11.9±1.7g/dL 
Mean height in cm 164.7±24.4 HT 93.2% (96/103) WBC 13±3 10
3
/μL 
Mean weight in kg 79.23±16.7 CAD 55.3% (57/103) Neu 72.8±9.5% 
Mean BMI in kg/m
2
 28±5.1 AF 12.6% (13/103) PLT 277±111 10
3
/μL 
Residency   PAD 53.4% (55/103) MPV 8.6±1.2 fL 
Urban  
53.4% 
(55/103) 
Mean ABI R 0.9±0.3 ESR 36.8±20.3mm/h 
Countryside 
46.6% 
(48/103) 
Mean ABI L 0.7±0.2 CRP 4.9±2.4mg/dL 
Occupation   
Patients with non-
compressible ABI 
29% (30/103) Cr 1.0±0.3mg/dL 
White collar worker 
25.2% 
(26/103)  DSA 
38.8% (40/103) Ur 45±26mg/dL 
Manual worker 
54.4% 
(56/103)  CTA 
2% (2/103) Na 137.2±14mmol/L 
Unemployed 
20.4% 
(21/103)  
CRD 20.4% (21/103)  K 4.6±1.2mmol/L 
Home carer   HL 74.8% (77/103) ALT 24±24 IU/L 
Spouse 
46.6% 
(48/103)  
COPD 11.7% (12/103) AST 28±25 IU/L 
Descendants 
47.6% 
(49/103)  
CVD 12.6% (13/103) CK 106±97U/L 
Alone  5.8% (6/103)  
History of alcohol 
consumption 
23.3% (24/103) LDH 202±92IU/L 
Family history of 
DM 
44.6% 
(46/103) 
History of 
smoking 
  Bilirubin 0.5±0.3mg/dL 
Family history of 
PAD 
15.5% 
(16/103) 
No 27.2% (28/103) Total Chol 167±52mg/dL 
Family history of 
CAD 
76.7% 
(79/103) 
Yes 25.2% (26/103) Trig 168±73mg/dL 
  
Ex smoker 47.6% (49/103) LDL 111±49mg/dL 
  
History of 
opthalmopathy 
  HDL 42±14mg/dL 
  
None 25.2% (26/103) INR 1±0.3 
  
Mild 42.7% (44/103) APTT  32.3±6sec 
  
Moderate 22.3% (23/103) PT 18.2±5sec 
  
Severe 9.7% (10/103) HbA1C  8.1±1.2% 
   
 
Negative ulcer 
cultures 
 63% (65/103) 
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Table 1. Social-demographics, past-medical history details and blood test results of 
each patient. 
BMI: body mass index; DM: diabetes mellitus; PAD: peripheral artery disease; CAD: 
coronary artery disease; HT: hypertension; AF: atrial fibrillation; ABI: ankle brachial 
index; DSA: digital subtraction angiography; CTA: computed tomography 
angiography; CRD: chronic renal disease; HL: hyperlipidemia; COPD: chronic 
obstructive pulmonary disease; CVD: cerebrovascular disease; Hb: hemoglobin; 
WBC: white blood cells;  Neu: neutrophils; PLT: platelets; MPV: mean platelet 
volume; ESR: erythrocyte sedimentation rate;  CRP: C-reactive protein; Cr: 
creatinine; Ur: Urea; Na: sodium; K: potassium; ALT: alanine transaminase; AST: 
aspartate transaminase; CK:  creatine kinase; LDH: lactate dehydrogenase; Chol: 
cholesterol; Trig: triglycerides; LDL: low-density lipoprotein; HDL: high-density 
lipoprotein; INR: international normalized ratio; APTT: activated partial 
thromboplastin time; PT: prothrombin time; HbA1C: hemoglobin A1C; cm: 
centimeter; kg: kilogram; m: meter; μl: microlitre; fl: femtolitre; mm: millimeter; h: 
hour; IU: International Units; L: Litre; mmol: millimole; U: units; dL: deciletre; sec: 
second. 
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i.  
Stage Grade 
 0 I II III 
A 0 3 0 0 
B 0 28 16 3 
C 0 30 10  
D 0 8 4 1 
 
ii.  
 Ischemia 0 Ischemia 1 Ischemia 2 Ischemia 3 
W0                 
W1 1 14    6 1  2 15 4  2 12   
W2  2 5 2   3   1 2   1 1  
W3    1       1      
 F0 F1 F2 F3 F0 F1 F2 F3 F0 F1 F2 F3 F0 F1 F2 F3 
 
 
Table 2. i. Patients categorized according to Texas Wound Classification system.
6
  
ii. Patients categorized according to Wound Ischemia Foot infection Classification 
system,
8
 (W: wound; F: foot infection). 
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 Mean Std. Deviation Std. Error Mean P values 
Pair 1 
Leisure after 12-month follow 
up 
45,8796 21,04544 2,02510  
Leisure at 1st examination 
 
29,0741 16,74643 1,61143 ,000 
Pair 2 
Physical health after 12-month 
follow up 
45,3704 19,55944 1,88211  
Physical health at 1st 
examination 
 
35,3704 17,23536 1,65847 ,000 
Pair 3 
Daily activities after 12-month 
follow up 
46,4815 21,16092 2,03621  
Daily activities at 1st 
examination 
 
35,3704 19,39149 1,86595 ,000 
Pair 4 
Emotions after 12-month 
follow up 
40,4861 21,45539 2,06455  
Emotions at 1st examination 
 
22,7083 16,58004 1,59542 ,000 
Pair 5 
Treatment after 12-month 
follow up 
45,1968 22,32484 2,14821  
Treatment at 1st examination 33,1019 18,05081 1,73694 ,000 
 
Table 3. Quality of life assessment in all domains at baseline (1
st
 examination) and at 
12-month follow up. 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
26/03/2018 13:05:52 EEST - 137.108.70.6
174 
 
Self-management 
 First examination After 12 month of follow up  
 Mean Self-
examination per 
week 
1.84 
Mean Self-
examination per week 
8.4 p< 0.05 
Mean Foot washing 
per week 
3.9 
Mean Foot washing 
per week 
7.8 p< 0.05 
Mean foot hydration 
per week 
0.66 
Mean foot hydration 
per week 
7 p< 0.05 
Cutting nails  
 
Cutting nails  
  
Him/herself  64% (66/103) Him/herself  11.6% (12/103) p< 0.05 
Other 34% (35/103) Other 70.9% (73/103) p< 0.05 
Specialist 2% (2/103) Specialist 17.4% (18/103) p< 0.05 
Sock selection 11.6% (12/103) Sock selection 79.6% (82/103) p< 0.05 
Special anatomical 
shoes 
 
Special anatomical 
shoes 
 
 
No 92.2% (95/103) No 80% (83/103) ns 
Walking barefoot: 
 
Walking barefoot: 
 
 
Yes 42.7% (44/103) Yes 7.6% (8/103) p< 0.05 
     
     
Visual analog scales 
Mean VAS ADL  6.8±2.5 Mean VAS ADL  4.2±1.2 p< 0.05 
Mean VAS INT 6.3±2.2 Mean VAS INT 2.8±1.3 p< 0.05 
 
Table 4.  Hygiene self-management assessment between the first and the last 
examination (12 months) of follow up. A 10 cm visual analogue scale for the impact 
of pain on daily living activities of (VAS-ADL) (0–10) and a 10 cm visual analog 
scale for the pain intensity (VAS-INT) (0, no pain; 10, unbearable pain. ns: not 
significant. 
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Part D 
 
1. Abstract- General Discussion 
 
According to the World Health Organization (WHO), it is possible 
to encompass all foot complications in the term diabetic foot ulcer (DFU) 
that has been defined as “ulceration of the foot associated with 
neuropathy and different grades of ischemia and infection.  Nowadays, it 
is apparent that DFU is a worldwide problem with a great impact on 
health care cost, the quality of life of the patient and its social 
environment and finally on the mortality and morbidity of those patients. 
Within this context we undertook a prospective non-randomized cohort 
study on consecutive diabetic patients with foot ulcer, to assess factors 
associated with the healing process or limb salvage, and evaluated the 
impact of their treatment on their quality of life (QOL). 
At the beginning, we conducted a survey under the auspices of the 
Mediterranean League of Angiology and Vascular Surgery (MLAVS) in 
order to highlight the current trends in the management of diabetic foot 
among Vascular Specialists practicing in the Mediterranean region. 
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From this first publication it was shown that most of the amputations 
were performed in tertiary hospitals, probably because diabetic foot is by 
far one of the worse complications in diabetic patients requiring dedicated 
vascular services that may not be available in small size hospitals in the 
Mediterranean region.
 
Even in the tertiary hospitals specialists involved 
with the treatment of diabetic foot were more experienced among their 
colleagues. Additionally, it was shown that vascular services involved in 
the management of diabetic foot patients had expertise in both 
endovascular and surgical skills (open, endovascular and hybrid), while 
specifically hybrid procedures were associated with lower rate of 
amputations. This reiterates that vascular services treating diabetic foot 
should be able to apply all types of interventions to optimize the 
outcomes. 
Another important finding of our study regarding the clinical 
assessment was the lack of complete clinical evaluation. Although ankle 
brachial index (ABI) has been recognized as a powerful tool for the 
detection of peripheral arterial disease, surprisingly it was underused by 
the vascular specialists responded to our survey. Additionally, only 60% 
of the vascular physicians considered as important to evaluate the patients 
for the presence of peripheral neuropathy before the treatment, although it 
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is known that this can predict
 
the risk of developing a diabetic foot ulcer 
or higher rate of amputation.  
Finally in this study, it was demonstrated that most of the vascular 
physicians had not adopted a multidisciplinary approach in the 
management of patients with diabetic foot as a routine in daily practice. 
This fact shows clearly that at least in the Mediterranean region the 
multidisciplinary approach of diabetic foot patients is not part of the 
standard care. Therefore, it appears that reorganization of the service 
provided to diabetic patients is of paramount importance in the healthcare 
system of the Mediterranean countries. 
In the second publication, we applied the Greek version of the 
LANSS (Leeds assessment of neuropathic symptoms and signs) 
questionnaire on patients with diagnosed (neuropathic pain) NP and 
assessed its validity. Additionally we investigated any association of 
LANNS with visual analog pain scales (VAS-ADL and VAS-INT). As a 
result, correlations of test-retest evaluation were statistically significant 
for total LANSS score as well as for questionnaires’ items. The Greek 
LANSS proved to be a valid instrument for NP assessment, since total 
score was strongly correlated with the type of pain; neuropathic pain 
group had significant higher LANSS scores; while the sensitivity and 
specificity of were 94.29% and 88.57% respectively.  In addition, it was 
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clearly shown that there was a significant correlation between LANNS 
score and VAS-ADL while there was no such relation noticed for VAS-
INT. Thus patients with higher LANNS score (in our case diabetic 
patients), answered that their pain had a greater impact on daily living 
activities, although the severity of the pain (VAS-INT) did not differ from 
that of patients with nociceptive pain.  This fact could suggest that NP 
may have a great impact on quality of life of diabetic patients and their 
daily activities, although this phenomenon is not always associated with 
the intensity of the pain. 
After the completion of follow up of all participants, in our third 
publication, we assessed the factors which were associated with the 
healing process or limb salvage, and evaluated the impact of their 
treatment on their quality of life (QOL). Firstly, it was demonstrated that 
patient with diabetic foot ulcer have an inadequate awareness about the 
nature of the disease. Almost half of our patients presented to our service 
late from the onset of the ulcer (mean time 24 days), with a poorly 
controlled diabetes mellitus (DM) (mean Hb1AC: 8.1% and BMI: 28) 
and low awareness of hygiene self-management. It is true that such 
patients may neglect themselves because of various reasons including 
impaired sensation due to neuropathy, impaired vision as a result of 
retinopathy, and other co-morbidities including cardiac and renal 
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impairment which all may contribute also to the lack of a personal alarm 
system.   However, it would seem advisable to implement strategies 
oriented towards the improvement of primary care physician awareness 
of diabetic foot and its complications, along the recommendations that 
healthcare professionals should receive periodic education to improve the 
care of high-risk individuals. After follow up, it was shown that the 
regular consultations of the patients by their physicians, led to an 
improvement of their hygiene self-management status considerably, 
decreasing the likelihood of a new ulcer. 
It is still debatable whether ulcer healing in diabetic patient always 
requires revascularization. In our study no differences were observed in 
respect to healing rate, minor and major amputation according to the type 
of intervention. Even in patients who were not considered candidates for 
revascularization, a reasonable healing rate was observed (46%, 31/67). 
However, this was an observational study and not designed to compare 
those treatments.  
Additionally, in our study it was demonstrated that initial clinical 
evaluation with the use of DFI score and TEXAS classification might 
help physicians to identify which patients are at increased risk for non-
healing ulcers or even limb loss, and in whom closer follow up and more 
aggressive treatment may be indicated. Texas classification, history of 
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COPD and LANSS score may also contribute to the identification of 
patients with high risk of minor amputation, while delay of hospital 
referral, the severity of PAD, and the prolonged hospitalization might 
identify those patients with high risk of major amputation.  
We have also underlined the importance of cardiovascular disease 
risk factor control as primary prevention in patients with DM 2 as it has 
been recommended from the American Heart Association and the 
American Diabetes Association. Thus, the majority of deaths in our 
cohort were cardiac related.  
Our study is the first to our knowledge that evaluates the QOL in 
the same group of patients before and after treatment. Thus, the presence 
of diabetic foot ulcer was associated with poor QOL, and QOL was 
significantly improved in all domains of throughout the cohort of our 
patients after the ulcer management. However, it was interesting, that 
QOL was improved regardless of patient outcome (healing, minor or 
major amputation) and no outcome was superior to another. Similarly, 
VASs were improved after treatment in our cohort. Even in cases that a 
major amputation was undertaken, the patients perceived their situation as 
improved in terms of QOL.  
In conclusion, during past 4 years, our experience suggests that 
patients with a diabetic foot ulcer should be always assessed holistically 
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with evaluation and management of intrinsic (health-related) and extrinsic 
(social-economic) factors. The need for co-operation among physicians 
and the function of a multidisciplinary diabetic foot team are mandatory. 
In the near future, a screening program could be organized in our region 
in order to assess the prevalence of diabetic foot. Additionally, the 
primary care network should be better organized in order to be capable of 
direct referrals of diabetic foot patients to tertiary centre, thus no valuable 
time would be lost during for diabetic foot patients.  
 
2. Summary of study limitations 
 
Finally, it should be acknowledged that our study may be inherent 
of some potential limitations. In the first publication, the response rate 
was 37.5%, which means that our results may not absolutely 
representative for the entire Mediterranean region. This is aggravated by 
the fact that our results were not analyzed with regard to the national 
origin of the physicians. Additionally, in this study only vascular 
physicians had participated, thus the results may be different if other 
specialties were available to take this survey such as Orthopedics or 
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General Surgeons. Also, we considered for granted that all patients were 
under the care of an endocrine-internal medicine physician. Nevertheless, 
besides these limitations, we still think that our survey provides a 
valuable snapshot on the current status regarding the management of 
diabetic foot patients in the Mediterranean region and our findings 
reiterate those reported in several other studies. 
 
 In the second publication, even though there is no widely 
established theoretical basis for determining sample size or power 
calculation in questionnaires psychometric validation, our sample size 
was relative small compared to the other LANSS validation studies. We 
also excluded patients with mixed pain so that our two study groups 
would be more homogenous and gave us more accurate results. This was 
also a limitation, since it could imply a bias of our study. One other 
potential limitation inherent in our study was the difference in the mean 
age between patients with NP and nociceptive pain. Nevertheless, it has 
not been reported any significant association among patients with NP or 
nociceptive pain and age. Finally, although we did not assess the impact 
of NP on quality of life with validated questionnaires, Visual Analogue 
Scales have provided us short information about the influence of NP on 
diabetic patients’ daily activity, which consists a rough approach of 
quality of life.  
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Finally, in the third publication, potential selection and treatment 
biases may exist as about 50% of patients had PAD, because this study 
was a prospective observational one, in patients referred to the Vascular 
Service of a tertiary Hospital. However, this reflects the real world 
practice of a Vascular Service which inevitably is committed to deal with 
more difficult-to-heal ulcers. 
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